Regional Monitoring EECA
by ECUO PLWH
Regional Monitoring EECA
Showing 1-876 of 876 items.
| # | Country | Source of financing | Manufacturer | Tradename | INN | Form | Price per unit ($) | Units in purchase | Units in package | Price per package ($) | Packages in purchase | Price per purchase ($) | Distributor | Year | Purchase date | Delivery date | Registered | In the list of main (vital) medications | WHO prequalification |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Russian Federation | Government | Pharmasyntez | Azimitem | Zidovudine (AZT or ZDV) | 100mg caps | 0.0819 | 4819100 | 100 | 8.19 | 48191 | 394684.28 | 2015 | Not specified | Not specified | Not specified | |||
| 2 | Republic of Poland | Government | ViiV Healthcare | Retrovir | Zidovudine (AZT or ZDV) | 100mg caps | 0.95 | 9000 | 100 | 95 | 90 | 8550 | 2015 | Not specified | Not specified | Not specified | |||
| 3 | Russian Federation | Government | Irwin 2 | Rinvir | Ritonavir (RTV) | 100mg caps | 1.1163 | 19980 | 30 | 33.49 | 666 | 22304.34 | 2015 | Not specified | Not specified | Not specified | |||
| 4 | Republic of Poland | Government | GlaxoSmithKline | Retrovir | Zidovudine (AZT or ZDV) | 100mg caps | 2.1595 | 2400 | 40 | 86.38 | 60 | 5182.8 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Yes | ||
| 5 | Republic of Poland | Government | GlaxoSmithKline | Retrovir | Zidovudine (AZT or ZDV) | 100mg caps | 0.8639 | 10000 | 100 | 86.39 | 100 | 8639 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Yes | Yes | ||
| 6 | Russian Federation | Government | LOK-BETA PHARMACEUTICALS | Ritonavir | Ritonavir (RTV) | 100mg caps | 0.81 | 2599500 | 30 | 24.3 | 86650 | 2105595 | 2016 | Yes | Yes | Yes | |||
| 7 | Russian Federation | Government | Abbott | Norvir | Ritonavir (RTV) | 100mg caps | 1.0629 | 5408100 | 90 | 95.66 | 60090 | 5748209.5 | 2015 | Not specified | Not specified | Not specified | |||
| 8 | Republic of Kazakhstan | Government | Abdi Ibrahim Global Farm | Zidoas | Zidovudine (AZT or ZDV) | 100mg caps | 0.0035 | 100 | 100 | 0.35 | 1 | 0.35 | 2016 | Yes | Yes | Not specified | |||
| 9 | Russian Federation | Government | Drugs technology | Zidovudine-AZT | Zidovudine (AZT or ZDV) | 100mg caps | 0.1088 | 2030100 | 100 | 10.88 | 20301 | 220874.88 | 2015 | Not specified | Not specified | Not specified | |||
| 10 | Russian Federation | Government | Biofarma | Azidothymidin | Zidovudine (AZT or ZDV) | 100mg caps | 0.1125 | 65800 | 100 | 11.25 | 658 | 7402.5 | 2015 | Not specified | Not specified | Not specified | |||
| 11 | Ukraine | Government | Aurobindo Pharma Ltd. | Zidovudine | Zidovudine (AZT or ZDV) | 100mg caps | 0.0631 | 23400 | 100 | 6.31 | 234 | 1476.54 | 2016 | Yes | Yes | Not specified | |||
| 12 | Republic of Kazakhstan | Government | S.C. Europharm S.A., Rumania | Zidovudine (AZT or ZDV) | 100mg caps | 0.0042 | 9660000 | 100 | 0.42 | 96600 | 40572 | 2015 | Not specified | Not specified | Not specified | ||||
| 13 | Russian Federation | Government | Hetero labs Ltd. | Ritonavir-100 | Ritonavir (RTV) | 100mg caps | 0.9443 | 10917540 | 60 | 56.66 | 181959 | 10309797 | 2015 | Not specified | Not specified | Not specified | |||
| 14 | Republic of Poland | Government | ViiV Healthcare | Retrovir | Zidovudine (AZT or ZDV) | 100mg caps | 0.95 | 8000 | 100 | 95 | 80 | 7600 | 2015 | Not specified | Not specified | Not specified | |||
| 15 | Russian Federation | Government | Pharmasyntez | Azimitem | Zidovudine (AZT or ZDV) | 100mg caps | 0.07 | 1229800 | 100 | 7 | 12298 | 86086 | 2016 | Yes | Yes | Not specified | |||
| 16 | Ukraine | Government | Aurobindo Pharma Ltd. | Zidovudine (AZT or ZDV) | 100mg caps | 0.063 | 23400 | 100 | 6.3 | 234 | 1474.2 | 2015 | Not specified | Not specified | Not specified | ||||
| 17 | Republic of Poland | Government | Merck Sharp & Dohme | Isentress | Raltegravir | 100mg tab | 7.1528 | 306000 | 60 | 429.17 | 5100 | 2188767 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Not specified | ||
| 18 | Republic of Poland | Government | AbbVie | Norvir | Ritonavir (RTV) | 100mg tab | 0.0903 | 360000 | 30 | 2.71 | 12000 | 32520 | 2015 | Not specified | Not specified | Not specified | |||
| 19 | Ukraine | Government | AbbVie | Ritonavir (RTV) | 100mg tab | 0.914 | 48480 | 30 | 27.42 | 1616 | 44310.72 | 2015 | Not specified | Not specified | Not specified | ||||
| 20 | Republic of Moldova | Global Fund | AbbVie | Ritonavir (RTV) | 100mg tab | 0.7193 | 18000 | 30 | 21.58 | 600 | 12948 | IDA Foundation | 2015 | Not specified | Yes | Not specified | |||
| 21 | Republic of Moldova | Global Fund | AbbVie | Ritonavir (RTV) | 100mg tab | 0.7193 | 32250 | 30 | 21.58 | 1075 | 23198.5 | IDA Foundation | Not specified | Not specified | Not specified | ||||
| 22 | Republic of Armenia | Global Fund | AbbVie | Norvir | Ritonavir (RTV) | 100mg tab | 1.096 | 960 | 30 | 32.88 | 32 | 1052.16 | partnership for supply. chain management (PFSCM) | 2016 | Yes | Yes | Not specified | ||
| 23 | Republic of Tajikistan | Global Fund | Merck Sharp & Dohme | Raltegravir | 100mg tab | 1.0533 | 2880 | 60 | 63.2 | 48 | 3033.6 | UNDP/UNICEF | Not specified | Not specified | Not specified | ||||
| 24 | Republic of Poland | Government | Janssen | Edurant | Etravirine | 100mg tab | 6.0847 | 21000 | 60 | 365.08 | 350 | 127778 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Not specified | Not specified | ||
| 25 | Republiс of Azerbaijan | Government | Hetero labs Ltd. | Ritonavir (RTV) | 100mg tab | 2.0167 | 5760 | 30 | 60.5 | 192 | 11616 | 2015 | Yes | Yes | Not specified | ||||
| 26 | Ukraine | PEPFAR | AbbVie | Norvir | Ritonavir (RTV) | 100mg tab | 0.855 | 21420 | 30 | 25.65 | 714 | 18314.1 | 2016 | Yes | Not specified | Not specified | |||
| 27 | Ukraine | Government | Janssen | Etravirine | 100mg tab | 2.8922 | 23880 | 120 | 347.06 | 199 | 69064.94 | 2015 | Not specified | Not specified | Not specified | ||||
| 28 | Georgia | NCDC Georgia | AbbVie | Norvir | Ritonavir (RTV) | 100mg tab | 1.096 | 21120 | 30 | 32.88 | 704 | 23147.52 | partnership for supply. chain management (PFSCM) | 2016 | Yes | Yes | Not specified | ||
| 29 | Republic of Kazakhstan | Government | JSC Nobel Almaty Pharmaceutical Factory | Lamivudine | 100mg tab | 0.023 | 239400 | 60 | 1.38 | 3990 | 5506.2 | 2015 | Not specified | Not specified | Not specified | ||||
| 30 | Republic of Belarus | Global Fund | AbbVie | Norvir | Ritonavir (RTV) | 100mg tab | 0.855 | 32430 | 30 | 25.65 | 1081 | 27727.65 | UNDP/UNICEF | 2016 | Yes | Yes | Not specified | ||
| 31 | Republic of Kazakhstan | Government | Ranbaxy Laboratories Limited | Didanosine | 100mg tab | 0.0245 | 2826000 | 60 | 1.47 | 47100 | 69237 | 2015 | Not specified | Not specified | Not specified | ||||
| 32 | Republic of Kazakhstan | Government | ViiV Healthcare | Lamivudine | 100mg tab | 0.025 | 1747200 | 60 | 1.5 | 29120 | 43680 | 2015 | Not specified | Not specified | Not specified | ||||
| 33 | Republic of Lithuania | Government | Merck Sharp & Dohme | Zeffix | Lamivudine | 100mg tab | 2.6661 | 28 | 28 | 74.65 | 1 | 74.65 | 2015 | Not specified | Not specified | Not specified | |||
| 34 | Republic of Poland | Government | AbbVie | Norvir | Ritonavir (RTV) | 100mg tab | 1.4583 | 450000 | 30 | 43.75 | 15000 | 656250 | 2015 | Not specified | Not specified | Not specified | |||
| 35 | Republic of Poland | Government | AbbVie | Norvir | Ritonavir (RTV) | 100mg tab | 1.286 | 45000 | 30 | 38.58 | 1500 | 57870 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Not specified | Not specified | ||
| 36 | Russian Federation | Government | Pharmasyntez | Regast | Efavirenz | 100mg tab | 0.064 | 959040 | 30 | 1.92 | 31968 | 61378.56 | 2016 | Yes | Yes | Not specified | |||
| 37 | Ukraine | Government | AbbVie | Norvir | Ritonavir (RTV) | 100mg tab | 0.9107 | 48480 | 30 | 27.32 | 1616 | 44149.12 | 2016 | Yes | Yes | Not specified | |||
| 38 | Republic of Armenia | Global Fund | AbbVie | Norvir | Ritonavir (RTV) | 100mg tab | 1.096 | 1680 | 30 | 32.88 | 56 | 1841.28 | partnership for supply. chain management (PFSCM) | 2016 | Yes | Yes | Not specified | ||
| 39 | Republic of Armenia | Global Fund | AbbVie | Ritonavir (RTV) | 100mg tab | 1.096 | 600 | 30 | 32.88 | 20 | 657.6 | VPP, through Partnership for Supply Chain Management (PFSCM) | 2015 | 2015-03-11 | 2015-10-14 | Not specified | Not specified | Not specified | |
| 40 | Republic of Poland | Government | AbbVie | Norvir | Ritonavir (RTV) | 100mg tab | 1.326 | 330000 | 30 | 39.78 | 11000 | 437580 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Not specified | ||
| 41 | Republic of Latvia | Government | Janssen-Cilag Internarional NV | Intelence | Etravirine | 100mg tab | 3.9863 | 3480 | 120 | 478.36 | 29 | 13872.44 | National Health Service (NHC) | 2016 | Not specified | Not specified | Not specified | ||
| 42 | Republic of Lithuania | Government | AbbVie | Norvir | Ritonavir (RTV) | 100mg tab | 1.0767 | 30 | 30 | 32.3 | 1 | 32.3 | 2015 | Not specified | Not specified | Not specified | |||
| 43 | Georgia | Global Fund | Janssen | Etravirine | 100mg tab | 4.7917 | 5760 | 120 | 575 | 48 | 27600 | partnership for supply. chain management (PFSCM) | 2015 | Not specified | Not specified | Not specified | |||
| 44 | Russian Federation | Government | Pharmasyntez | Regast | Efavirenz | 100mg tab | 0.075 | 227370 | 30 | 2.25 | 7579 | 17052.75 | 2015 | Not specified | Not specified | Not specified | |||
| 45 | Republic of Tajikistan | Global Fund | LOK-BETA PHARMACEUTICALS | Ritonavir (RTV) | 100mg tab | 0.4533 | 2880 | 60 | 27.2 | 48 | 1305.6 | UNDP/UNICEF | Not specified | Not specified | Not specified | ||||
| 46 | Republic of Lithuania | Insurance Fund | AbbVie | Norvir | Ritonavir (RTV) | 100mg tab | 1.1303 | 30 | 30 | 33.91 | 1 | 33.91 | 2016 | Yes | Yes | Not specified | |||
| 47 | Georgia | Global Fund | AbbVie | Ritonavir (RTV) | 100mg tab | 1.096 | 62280 | 30 | 32.88 | 2076 | 68258.88 | partnership for supply. chain management (PFSCM) | 2015 | Yes | Not specified | Not specified | |||
| 48 | Republic of Poland | Government | Janssen | Intelence | Etravirine | 100mg tab | 6.0847 | 21000 | 60 | 365.08 | 350 | 127778 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Not specified | Yes | ||
| 49 | Republic of Moldova | Global Fund | AbbVie | Ritonavir (RTV) | 100mg tab | 0.7193 | 14250 | 30 | 21.58 | 475 | 10250.5 | 2015 | Not specified | Not specified | Not specified | ||||
| 50 | Georgia | NCDC Georgia | Janssen | Intelence | Etravirine | 100mg tab | 2.5 | 7080 | 120 | 300 | 59 | 17700 | partnership for supply. chain management (PFSCM) | 2016 | Yes | Yes | Yes | ||
| 51 | Russian Federation | Government | Johnson & Johnson | Intelence | Etravirine | 100mg tab | 2.7487 | 454440 | 120 | 329.85 | 3787 | 1249142 | 2015 | Not specified | Not specified | Not specified | |||
| 52 | Republic of Latvia | Government | Johnson & Johnson | Intelence | Etravirine | 100mg tab | 3.5232 | 120 | 120 | 422.79 | 1 | 422.79 | 2015 | Not specified | Not specified | Not specified | |||
| 53 | Kyrgyz Republic | Global Fund | Hetero labs Ltd. | Lamivudine | 100mg tab | 0.0383 | - | 60 | 2.3 | - | - | UNDP/UNICEF | 2015 | 2014-12-31 | 2015-12-30 | Not specified | Not specified | Not specified | |
| 54 | Republic of Latvia | Government | Merck Sharp & Dohme | Isentress | Raltegravir | 100mg tab | 3.0653 | 60 | 60 | 183.92 | 1 | 183.92 | 2015 | Not specified | Not specified | Not specified | |||
| 55 | Republic of Belarus | Global Fund | AbbVie | Ritonavir (RTV) | 100mg tab | 0.855 | 21600 | 30 | 25.65 | 720 | 18468 | UNICEF Supply Division | 2015 | 2015-12-22 | 2016-05-21 | Not specified | Not specified | Not specified | |
| 56 | Republic of Latvia | Government | AbbVie | Norvir | Ritonavir (RTV) | 100mg tab | 0.748 | 30 | 30 | 22.44 | 1 | 22.44 | 2015 | Not specified | Not specified | Not specified | |||
| 57 | Republic of Lithuania | Insurance Fund | Merck Sharp & Dohme | Isentress | Raltegravir | 100mg tab | 12.6053 | 60 | 60 | 756.32 | 1 | 756.32 | 2016 | Yes | Yes | Not specified | |||
| 58 | Ukraine | Government | Janssen | Intelence | Etravirine | 100mg tab | 2.8876 | 23880 | 120 | 346.51 | 199 | 68955.49 | 2016 | Yes | Yes | Yes | |||
| 59 | Ukraine | Government | AbbVie | Aluvia | Lopinavir+Ritonavir - FDC | 100mg+25mg tab | 0.27 | 1301520 | 60 | 16.2 | 21692 | 351410.41 | Yes | Not specified | Not specified | ||||
| 60 | Republic of Latvia | Government | AbbVie | Kaletra | Lopinavir+Ritonavir - FDC | 100mg+25mg tab | 2.029 | 3960 | 60 | 121.74 | 66 | 8034.84 | National Health Service (NHC) | 2016 | Not specified | Not specified | Not specified | ||
| 61 | Republic of Tajikistan | Global Fund | AbbVie | Lopinavir+Ritonavir - FDC | 100mg+25mg tab | 0.1283 | 60 | 60 | 7.7 | 1 | 7.7 | 2015 | Not specified | Not specified | Not specified | ||||
| 62 | Republic of Moldova | Global Fund | AbbVie | Lopinavir+Ritonavir - FDC | 100mg+25mg tab | 0.3497 | 14400 | 60 | 20.98 | 240 | 5035.2 | 2015 | Not specified | Not specified | Not specified | ||||
| 63 | Russian Federation | Government | Abbott | Kaletra | Lopinavir+Ritonavir - FDC | 100mg+25mg tab | 1.7248 | 943440 | 60 | 103.49 | 15724 | 1627276.75 | 2015 | Not specified | Not specified | Not specified | |||
| 64 | Republic of Kazakhstan | Government | AbbVie | Lopinavir+Ritonavir - FDC | 100mg+25mg tab | 0.0078 | 85190400 | 60 | 0.47 | 1419840 | 667324.81 | 2015 | Not specified | Not specified | Not specified | ||||
| 65 | Republic of Kazakhstan | Government | AbbVie | Lopinavir+Ritonavir - FDC | 100mg+25mg tab | 0.0022 | 4428000 | 60 | 0.13 | 73800 | 9594 | 2015 | Not specified | Not specified | Not specified | ||||
| 66 | Republic of Poland | Government | AbbVie | Kaletra | Lopinavir+Ritonavir - FDC | 100mg+25mg tab | 3.1157 | 4200 | 60 | 186.94 | 70 | 13085.8 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Not specified | ||
| 67 | Republic of Poland | Government | AbbVie | Kaletra | Lopinavir+Ritonavir - FDC | 100mg+25mg tab | 3.4292 | 4800 | 60 | 205.75 | 80 | 16460 | 2015 | Not specified | Not specified | Not specified | |||
| 68 | Republic of Poland | Government | AbbVie | Kaletra | Lopinavir+Ritonavir - FDC | 100mg+25mg tab | 3.4292 | 15000 | 60 | 205.75 | 250 | 51437.5 | 2015 | Not specified | Not specified | Not specified | |||
| 69 | Republic of Latvia | Government | AbbVie | Kaletra | Lopinavir+Ritonavir - FDC | 100mg+25mg tab | 1.7137 | 60 | 60 | 102.82 | 1 | 102.82 | 2015 | Not specified | Not specified | Not specified | |||
| 70 | Georgia | Global Fund | AbbVie | Aluvia | Lopinavir+Ritonavir - FDC | 100mg+25mg tab | 0.5067 | 18960 | 120 | 60.8 | 158 | 9606.4 | partnership for supply. chain management (PFSCM) | 2016 | Yes | Yes | Not specified | ||
| 71 | Republic of Moldova | Global Fund | AbbVie | Lopinavir+Ritonavir - FDC | 100mg+25mg tab | 0.3497 | 13920 | 60 | 20.98 | 232 | 4867.36 | 2015 | Not specified | Not specified | Not specified | ||||
| 72 | Republic of Moldova | Global Fund | AbbVie | Aluvia | Lopinavir+Ritonavir - FDC | 100mg+25mg tab | 0.3497 | 28320 | 60 | 20.98 | 472 | 9902.56 | IDA Foundation | Not specified | Not specified | Not specified | |||
| 73 | Ukraine | PEPFAR | AbbVie | Aluvia | Lopinavir+Ritonavir - FDC | 100mg+25mg tab | 0.2535 | 174780 | 60 | 15.21 | 2913 | 44306.73 | 2016 | Yes | Yes | Not specified | |||
| 74 | Republic of Poland | Government | AbbVie | Kaletra | Lopinavir+Ritonavir - FDC | 100mg+25mg tab | 3.0222 | 291600 | 120 | 362.66 | 2430 | 881263.81 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Not specified | Not specified | ||
| 75 | Republic of Tajikistan | Global Fund | Aurobindo Pharma Ltd. | Lopinavir+Ritonavir - FDC | 100mg+25mg tab | 0.1283 | 77760 | 60 | 7.7 | 1296 | 9979.2 | UNDP/UNICEF | Not specified | Not specified | Not specified | ||||
| 76 | Ukraine | Government | AbbVie | Lopinavir+Ritonavir - FDC | 100mg+25mg tab | 0.2708 | 1301460 | 60 | 16.25 | 21691 | 352478.75 | 2015 | Not specified | Not specified | Not specified | ||||
| 77 | Republic of Moldova | Government | AbbVie | Aluvia | Lopinavir+Ritonavir - FDC | 100mg+25mg tab | 0.3127 | 73920 | 60 | 18.76 | 1232 | 23112.32 | Dita Estfarm SRL | Not specified | Not specified | Not specified | |||
| 78 | Republic of Poland | Government | AbbVie | Kaletra | Lopinavir+Ritonavir - FDC | 100mg+25mg tab | 3.1182 | 24000 | 120 | 374.18 | 200 | 74836 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Yes | Not specified | ||
| 79 | Republic of Lithuania | Insurance Fund | AbbVie | Kaletra | Lopinavir+Ritonavir - FDC | 100mg+25mg tab | 3.5633 | 120 | 120 | 427.6 | 1 | 427.6 | 2016 | Yes | Yes | Not specified | |||
| 80 | Republic of Lithuania | Government | AbbVie | Kaletra | Lopinavir+Ritonavir - FDC | 100mg+25mg tab | 1.6968 | 60 | 60 | 101.81 | 1 | 101.81 | 2015 | Not specified | Yes | Not specified | |||
| 81 | Russian Federation | Government | AbbVie | Kaletra | Lopinavir+Ritonavir - FDC | 100mg+25mg tab | 1.537 | 50520 | 60 | 92.22 | 842 | 77649.24 | 2016 | Yes | Yes | Not specified | |||
| 82 | Republic of Poland | Government | AbbVie | Kaletra | Lopinavir+Ritonavir - FDC | 100mg+25mg tab | 3.1157 | 744000 | 120 | 373.88 | 6200 | 2318056 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Not specified | ||
| 83 | Republic of Poland | Government | Roche | Fuzeon | Enfuvirtide | 108mg/ml infusion solution 1 ml | 26.5615 | 480 | 60 | 1593.69 | 8 | 12749.52 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Not specified | ||
| 84 | Republic of Latvia | Government | Roche | Fuzeon | Enfuvirtide | 108mg/ml infusion solution 1 ml | 27.4897 | 840 | 60 | 1649.38 | 14 | 23091.32 | National Health Service (NHC) | 2016 | Not specified | Not specified | Not specified | ||
| 85 | Russian Federation | Government | Roche | Fuzeon | Enfuvirtide | 108mg/ml infusion solution 1 ml | 18.1703 | 26940 | 60 | 1090.22 | 449 | 489508.78 | 2015 | Not specified | Not specified | Not specified | |||
| 86 | Republic of Latvia | Government | Roche | Fuzeon | Enfuvirtide | 108mg/ml infusion solution 1 ml | 24.5577 | 60 | 60 | 1473.46 | 1 | 1473.46 | 2015 | Not specified | Not specified | Not specified | |||
| 87 | Russian Federation | Government | Roche | Fuzeon | Enfuvirtide | 108mg/ml infusion solution 1 ml | 16 | 17940 | - | - | - | 287040 | 2016 | Yes | Yes | Not specified | |||
| 88 | Republic of Poland | Government | Roche | Fuzeon | Enfuvirtide | 108mg/ml infusion solution 1 ml | 27.75 | 1200 | 60 | 1665 | 20 | 33300 | 2015 | Not specified | Not specified | Not specified | |||
| 89 | Republic of Poland | Government | GlaxoSmithKline | Retrovir | Zidovudine (AZT or ZDV) | 10mg/ml infusion solution 20ml | 11.246 | 200 | 5 | 56.23 | 40 | 2249.2 | 2016 | Not specified | Not specified | Yes | |||
| 90 | Russian Federation | Government | ViiV Healthcare | Retrovir | Zidovudine (AZT or ZDV) | 10mg/ml infusion solution 20ml | 8.802 | 42190 | 5 | 44.01 | 8438 | 371356.38 | 2015 | Not specified | Not specified | Not specified | |||
| 91 | Georgia | Global Fund | ViiV Healthcare | Zidovudine (AZT or ZDV) | 10mg/ml infusion solution 20ml | 6.58 | 200 | 5 | 32.9 | 40 | 1316 | partnership for supply. chain management (PFSCM) | 2015 | Not specified | Not specified | Not specified | |||
| 92 | Russian Federation | Government | ViiV Healthcare | Retrovir | Zidovudine (AZT or ZDV) | 10mg/ml infusion solution 20ml | 5.55 | 1357 | 1 | 5.55 | 1357 | 7531.35 | 2016 | Yes | Yes | Not specified | |||
| 93 | Republic of Poland | Government | ViiV Healthcare | Retrovir | Zidovudine (AZT or ZDV) | 10mg/ml infusion solution 20ml | 11.75 | 95 | 5 | 58.75 | 19 | 1116.25 | 2015 | Not specified | Not specified | Not specified | |||
| 94 | Republic of Belarus | Global Fund | GlaxoSmithKline | Retrovir | Zidovudine (AZT or ZDV) | 10mg/ml infusion solution 20ml | 3.95 | 700 | 20 | 79 | 35 | 2765 | UNDP/UNICEF | 2016 | Yes | Yes | Yes | ||
| 95 | Republic of Belarus | Global Fund | ViiV Healthcare | Zidovudine (AZT or ZDV) | 10mg/ml infusion solution 20ml | 5.9 | 850 | 5 | 29.5 | 170 | 5015 | IDA Foundation | 2015 | 2015-12-22 | 2016-05-29 | Not specified | Not specified | Not specified | |
| 96 | Republic of Tajikistan | Global Fund | Cipla Ltd | Lamivudine | 10mg/ml oral solution 100ml | 1.2 | 4320 | 1 | 1.2 | 4320 | 5184 | UNDP/UNICEF | 2016 | Not specified | Not specified | Not specified | |||
| 97 | Republic of Belarus | Global Fund | Cipla Ltd | Nevirapine (NVP) | 10mg/ml oral solution 100ml | 1.38 | 432 | 1 | 1.38 | 432 | 596.16 | UNDP/UNICEF | 2016 | No | Yes | Not specified | |||
| 98 | Republic of Belarus | Global Fund | Aurobindo Pharma Ltd. | Nevirapine (NVP) | 10mg/ml oral solution 100ml | 1.5 | 432 | 1 | 1.5 | 432 | 648 | IDA Foundation | 2015 | 2015-12-22 | 2016-05-28 | Not specified | Not specified | Not specified | |
| 99 | Republic of Tajikistan | Global Fund | Hetero labs Ltd. | Lamivudine | 10mg/ml oral solution 100ml | 1.2 | - | 1 | 1.2 | - | - | 2015 | Not specified | Not specified | Not specified | ||||
| 100 | Ukraine | Government | Aurobindo Pharma Ltd. | Zidovudine | Zidovudine (AZT or ZDV) | 10mg/ml oral solution 100ml | 5.03 | 9627 | 1 | 5.03 | 9627 | 48423.81 | 2016 | Yes | Not specified | Not specified | |||
| 101 | Ukraine | Government | Cipla Ltd | Nevirapine (NVP) | 10mg/ml oral solution 100ml | 0.01 | 190000 | 1 | 0.01 | 190000 | 1900 | 2015 | Not specified | Not specified | Not specified | ||||
| 102 | Republic of Armenia | Global Fund | Cipla Ltd | Nevirapine (NVP) | 10mg/ml oral solution 100ml | 1.25 | 84 | 1 | 1.25 | 84 | 105 | VPP, through Partnership for Supply Chain Management (PFSCM) | 2015 | 2015-03-11 | 2015-10-14 | Not specified | Not specified | Not specified | |
| 103 | Ukraine | Government | Cipla Ltd | Nevimun | Nevirapine (NVP) | 10mg/ml oral solution 100ml | 2 | 1848 | 1 | 2 | 1848 | 3696 | 2016 | Yes | Yes | Yes | |||
| 104 | Republic of Uzbekistan | Global Fund | Cipla Ltd | Nevimun | Nevirapine (NVP) | 10mg/ml oral solution 100ml | 1.25 | 1 | 1 | 1.25 | 1 | 1.25 | 2016 | No | Yes | Yes | |||
| 105 | Republic of Uzbekistan | Global Fund | Cipla Ltd | Nevirapine (NVP) | 10mg/ml oral solution 100ml | 1.25 | - | 1 | 1.25 | - | - | 2015 | Not specified | Not specified | Not specified | ||||
| 106 | Russian Federation | Government | Boehringer Ingelheim | Viramune | Nevirapine (NVP) | 10mg/ml oral solution 100ml | 10.78 | 210 | 1 | 10.78 | 210 | 2263.8 | 2016 | Yes | Yes | Not specified | |||
| 107 | Ukraine | Government | Aurobindo Pharma Ltd. | Zidovudine (AZT or ZDV) | 10mg/ml oral solution 100ml | 0.02 | 2310600 | 1 | 0.02 | 2310600 | 46212 | 2015 | Not specified | Not specified | Not specified | ||||
| 108 | Republic of Armenia | Global Fund | Aurobindo Pharma Ltd. | Zidovudine (AZT or ZDV) | 10mg/ml oral solution 100ml | 2 | 15 | 1 | 2 | 15 | 30 | partnership for supply. chain management (PFSCM) | 2016 | No | Yes | Not specified | |||
| 109 | Republic of Belarus | Global Fund | Cipla Ltd | Nevirapine (NVP) | 10mg/ml oral solution 100ml | 1.25 | 10008 | 1 | 1.25 | 10008 | 12510 | UNDP/UNICEF | 2016 | No | Yes | Not specified | |||
| 110 | Republic of Tajikistan | Global Fund | Cipla Ltd | Nevirapine (NVP) | 10mg/ml oral solution 100ml | 1.3 | 1140 | 1 | 1.3 | 1140 | 1482 | UNDP/UNICEF | 2016 | Not specified | Not specified | Not specified | |||
| 111 | Kyrgyz Republic | Global Fund | Cipla Ltd | Nevirapine (NVP) | 10mg/ml oral solution 100ml | 2.33 | 55 | 1 | 2.33 | 55 | 128.15 | UNDP/UNICEF | 2015 | 2014-12-31 | 2015-12-30 | Not specified | Not specified | Not specified | |
| 112 | Russian Federation | Government | ViiV Healthcare | Epivir | Zidovudine (AZT or ZDV) | 10mg/ml oral solution 100ml | 18.57 | 793 | 1 | 18.57 | 793 | 14726.01 | 2016 | Yes | Yes | Not specified | |||
| 113 | Republic of Uzbekistan | Global Fund | Cipla Ltd | Lamivudine | 10mg/ml oral solution 100ml | 2.2 | - | 1 | 2.2 | - | - | 2015 | Not specified | Not specified | Not specified | ||||
| 114 | Republic of Uzbekistan | Global Fund | Cipla Ltd | Lamivir | Lamivudine | 10mg/ml oral solution 100ml | 2.2 | 1 | 1 | 2.2 | 1 | 2.2 | 2016 | No | Yes | Yes | |||
| 115 | Republic of Tajikistan | Global Fund | Aurobindo Pharma Ltd. | Nevirapine (NVP) | 10mg/ml oral solution 100ml | 1.25 | - | 1 | 1.25 | - | - | 2015 | Not specified | Not specified | Not specified | ||||
| 116 | Ukraine | Government | Cipla Ltd | Lamivir | Lamivudine | 10mg/ml oral solution 100ml | 1.86 | 7896 | 1 | 1.86 | 7896 | 14686.56 | 2016 | Yes | Not specified | Yes | |||
| 117 | Republic of Uzbekistan | Global Fund | Aurobindo Pharma Ltd. | Zidovudine (AZT or ZDV) | 10mg/ml oral solution 100ml | 2 | - | 1 | 2 | - | - | 2015 | Not specified | Not specified | Not specified | ||||
| 118 | Kyrgyz Republic | Global Fund | Cipla Ltd | Zidovudine (AZT or ZDV) | 10mg/ml oral solution 100ml | 2.79 | - | 1 | 2.79 | - | - | UNDP/UNICEF | 2015 | 2014-12-31 | 2015-12-30 | Not specified | Not specified | Not specified | |
| 119 | Ukraine | Government | Cipla Ltd | Lamivudine | 10mg/ml oral solution 100ml | 0.01 | 792596 | 1 | 0.01 | 792596 | 7925.96 | 2015 | Not specified | Not specified | Not specified | ||||
| 120 | Republic of Armenia | Global Fund | Cipla Ltd | Lamivir | Lamivudine | 10mg/ml oral solution 100ml | 1.2 | 80 | 1 | 1.2 | 80 | 96 | partnership for supply. chain management (PFSCM) | 2016 | No | Yes | Yes | ||
| 121 | Republic of Moldova | Government | Viiv Healthcare UK Limited | retrovir | Zidovudine (AZT or ZDV) | 10mg/ml oral solution 200ml | 30.01 | 120 | 1 | 30.01 | 120 | 3601.2 | Dita Estfarm SRL | 2015 | Not specified | Not specified | Not specified | ||
| 122 | Republic of Estonia | Government | ViiV Healthcare | Retrovir | Zidovudine (AZT or ZDV) | 10mg/ml oral solution 200ml | 86.63 | - | 1 | 86.63 | - | - | 2015 | Not specified | Not specified | Not specified | |||
| 123 | Republic of Poland | Government | ViiV Healthcare | Retrovir | Zidovudine (AZT or ZDV) | 10mg/ml oral solution 200ml | 23.75 | 120 | 1 | 23.75 | 120 | 2850 | 2015 | Not specified | Not specified | Not specified | |||
| 124 | Republic of Poland | Government | ViiV Healthcare | Retrovir | Zidovudine (AZT or ZDV) | 10mg/ml oral solution 200ml | 23.75 | 150 | 1 | 23.75 | 150 | 3562.5 | 2015 | Not specified | Not specified | Not specified | |||
| 125 | Russian Federation | Government | ViiV Healthcare | Retrovir | Zidovudine (AZT or ZDV) | 10mg/ml oral solution 200ml | 17.58 | 30231 | 1 | 17.58 | 30231 | 531461 | 2015 | Not specified | Not specified | Not specified | |||
| 126 | Republic of Poland | Government | GlaxoSmithKline | Retrovir | Zidovudine (AZT or ZDV) | 10mg/ml oral solution 200ml | 22.73 | 150 | 1 | 22.73 | 150 | 3409.5 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Yes | ||
| 127 | Republic of Poland | Government | GlaxoSmithKline | Retrovir | Zidovudine (AZT or ZDV) | 10mg/ml oral solution 200ml | 35.46 | 100 | 1 | 35.46 | 100 | 3546 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Yes | Yes | ||
| 128 | Republic of Kazakhstan | Government | GlaxoSmithKline | Retrovir | Zidovudine (AZT or ZDV) | 10mg/ml oral solution 200ml | 21.7 | 1 | 1 | 21.7 | 1 | 21.7 | 2016 | Yes | Yes | Yes | |||
| 129 | Republic of Poland | Government | ViiV Healthcare | Epivir | Lamivudine | 10mg/ml oral solution 240ml | 47.5 | 450 | 1 | 47.5 | 450 | 21375 | 2015 | Not specified | Not specified | Not specified | |||
| 130 | Republic of Belarus | Global Fund | Aurobindo Pharma Ltd. | Zidovudine | Zidovudine (AZT or ZDV) | 10mg/ml oral solution 240ml | 2 | 842 | 1 | 2 | 842 | 1684 | UNDP/UNICEF | 2016 | Yes | Yes | Not specified | ||
| 131 | Republic of Kazakhstan | Government | ViiV Healthcare | Epivir | Lamivudine | 10mg/ml oral solution 240ml | 24.66 | 3740 | 1 | 24.66 | 3740 | 92228.4 | 2015 | Not specified | Not specified | Not specified | |||
| 132 | Republic of Tajikistan | Global Fund | Aurobindo Pharma Ltd. | Zidovudine (AZT or ZDV) | 10mg/ml oral solution 240ml | 1.2 | 2064 | 1 | 1.2 | 2064 | 2476.8 | UNDP/UNICEF | 2016 | Not specified | Not specified | Not specified | |||
| 133 | Republic of Kazakhstan | Government | ViiV Healthcare | Zidovudine (AZT or ZDV) | 10mg/ml oral solution 240ml | 28.32 | 5321 | 1 | 28.32 | 5321 | 150690.72 | 2015 | Not specified | Not specified | Not specified | ||||
| 134 | Russian Federation | Government | ViiV Healthcare | Retrovir | Zidovudine (AZT or ZDV) | 10mg/ml oral solution 240ml | 11.43 | 684 | 1 | 11.43 | 684 | 7818.12 | 2016 | Not specified | Yes | Not specified | |||
| 135 | Republic of Moldova | Global Fund | Aurobindo Pharma Ltd. | Zidovudine (AZT or ZDV) | 10mg/ml oral solution 240ml | 10.69 | 85 | 1 | 10.69 | 85 | 908.65 | IDA Foundation | Not specified | Not specified | Not specified | ||||
| 136 | Republic of Tajikistan | Global Fund | ViiV Healthcare | Zidovudine (AZT or ZDV) | 10mg/ml oral solution 240ml | 2.25 | - | 1 | 2.25 | - | - | 2015 | Not specified | Not specified | Not specified | ||||
| 137 | Republiс of Azerbaijan | Government | Cipla Ltd | Nevirapine (NVP) | 10mg/ml oral solution 240ml | 10 | 80 | 1 | 10 | 80 | 800 | 2015 | Yes | Yes | Not specified | ||||
| 138 | Republic of Kazakhstan | Government | Boehringer Ingelheim | Viramune | Nevirapine (NVP) | 10mg/ml oral solution 240ml | 19.76 | 4010 | 1 | 19.76 | 4010 | 79237.6 | 2015 | Not specified | Not specified | Not specified | |||
| 139 | Georgia | Global Fund | Aurobindo Pharma Ltd. | Zidovudine | Zidovudine (AZT or ZDV) | 10mg/ml oral solution 240ml | 2 | 32 | 1 | 2 | 32 | 64 | partnership for supply. chain management (PFSCM) | 2016 | Not specified | Yes | Not specified | ||
| 140 | Republic of Moldova | Government | Hetero labs Ltd. | Nevirapine (NVP) | 10mg/ml oral solution 240ml | 13.55 | 50 | 1 | 13.55 | 50 | 677.5 | Sanfarm-Prim SA | Not specified | Not specified | Not specified | ||||
| 141 | Republic of Moldova | Global Fund | Hetero labs Ltd. | Lamivudine | 10mg/ml oral solution 240ml | 10.69 | 15 | 1 | 10.69 | 15 | 160.35 | IDA Foundation | 2015 | Not specified | Yes | Not specified | |||
| 142 | Republic of Belarus | Global Fund | Aurobindo Pharma Ltd. | Zidovudine (AZT or ZDV) | 10mg/ml oral solution 240ml | 2 | 320 | 1 | 2 | 320 | 640 | UNICEF Supply Division | 2015 | 2015-12-22 | 2016-06-22 | Not specified | Not specified | Not specified | |
| 143 | Republic of Moldova | Global Fund | Hetero labs Ltd. | Nevirapine (NVP) | 10mg/ml oral solution 240ml | 10.52 | 15 | 1 | 10.52 | 15 | 157.8 | IDA Foundation | Not specified | Not specified | Not specified | ||||
| 144 | Republic of Tajikistan | Global Fund | Hetero labs Ltd. | Zidovudine (AZT or ZDV) | 10mg/ml oral solution 240ml | 2.25 | - | 1 | 2.25 | - | - | 2015 | Not specified | Not specified | Not specified | ||||
| 145 | Republiс of Azerbaijan | Government | Aurobindo Pharma Ltd. | Zidovudine (AZT or ZDV) | 10mg/ml oral solution 240ml | 12.64 | 45 | 1 | 12.64 | 45 | 568.8 | 2015 | Yes | Yes | Not specified | ||||
| 146 | Georgia | Global Fund | Hetero labs Ltd. | Lamivudine | 10mg/ml oral solution 240ml | 1.95 | 400 | 1 | 1.95 | 400 | 780 | partnership for supply. chain management (PFSCM) | 2015 | Not specified | Not specified | Not specified | |||
| 147 | Republic of Armenia | Global Fund | Hetero labs Ltd. | Lamivudine | 10mg/ml oral solution 240ml | 1.53 | 39 | 1 | 1.53 | 39 | 59.67 | VPP, through Partnership for Supply Chain Management (PFSCM) | 2015 | 2015-03-11 | 2015-10-14 | Not specified | Not specified | Not specified | |
| 148 | Republic of Poland | Government | GlaxoSmithKline | Epivir | Lamivudine | 10mg/ml oral solution 240ml | 45.47 | 150 | 1 | 45.47 | 150 | 6820.5 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Not specified | ||
| 149 | Republic of Moldova | Global Fund | Hetero labs Ltd. | Zidovudine (AZT or ZDV) | 10mg/ml oral solution 240ml | 4.19 | 85 | 1 | 4.19 | 85 | 356.15 | IDA Foundation | 2015 | Not specified | Yes | Not specified | |||
| 150 | Republic of Poland | Government | GlaxoSmithKline | Epivir | Lamivudine | 10mg/ml oral solution 240ml | 45.46 | 30 | 1 | 45.46 | 30 | 1363.8 | Krajowe Centrum ds. AIDS | Yes | Yes | Not specified | |||
| 151 | Republic of Poland | Government | GlaxoSmithKline | Epivir | Lamivudine | 10mg/ml oral solution 240ml | 106.84 | 100 | 1 | 106.84 | 100 | 10684 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Not specified | Not specified | ||
| 152 | Republic of Latvia | Government | ViiV Healthcare | Epivir | Lamivudine | 10mg/ml oral solution 240ml | 38.04 | - | 1 | 38.04 | - | - | 2015 | Not specified | Not specified | Not specified | |||
| 153 | Georgia | Global Fund | Hetero labs Ltd. | Zidovudine (AZT or ZDV) | 10mg/ml oral solution 240ml | 2 | 184 | 1 | 2 | 184 | 368 | partnership for supply. chain management (PFSCM) | 2015 | Not specified | Not specified | Not specified | |||
| 154 | Republic of Armenia | Global Fund | Cipla Ltd | Zidovudine (AZT or ZDV) | 10mg/ml oral solution 240ml | 2.15 | 79 | 1 | 2.15 | 79 | 169.85 | VPP, through Partnership for Supply Chain Management (PFSCM) | 2015 | 2015-03-11 | 2015-10-14 | Not specified | Not specified | Not specified | |
| 155 | Republic of Moldova | Global Fund | Aurobindo Pharma Ltd. | Nevirapine (NVP) | 10mg/ml oral solution 240ml | 10.52 | 15 | 1 | 10.52 | 15 | 157.8 | 2015 | Not specified | Not specified | Not specified | ||||
| 156 | Republic of Moldova | Government | Viiv Healthcare UK Limited | retrovir | Zidovudine (AZT or ZDV) | 10mg/ml oral solution 240ml | 13.45 | 200 | 1 | 13.45 | 200 | 2690 | Sanfarm-Prim SA | Not specified | Not specified | Not specified | |||
| 157 | Republic of Poland | Government | Boehringer Ingelheim | Viramune | Nevirapine (NVP) | 10mg/ml oral solution 240ml | 55.3 | 150 | 1 | 55.3 | 150 | 8295 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Not specified | Not specified | ||
| 158 | Russian Federation | Government | ViiV Healthcare | Epivir | Lamivudine | 10mg/ml oral solution 240ml | 30.57 | 44581 | 1 | 30.57 | 44581 | 1362841.12 | 2015 | Not specified | Not specified | Not specified | |||
| 159 | Republic of Tajikistan | Global Fund | Boehringer Ingelheim | Nevirapine (NVP) | 10mg/ml oral solution 240ml | 1.35 | - | 1 | 1.35 | - | - | 2015 | Not specified | Not specified | Not specified | ||||
| 160 | Republic of Poland | Government | Boehringer Ingelheim | Viramune | Nevirapine (NVP) | 10mg/ml oral solution 240ml | 55.3 | 80 | 1 | 55.3 | 80 | 4424 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Not specified | ||
| 161 | Republiс of Azerbaijan | Government | Aurobindo Pharma Ltd. | Lamivudine | 10mg/ml oral solution 240ml | 8.14 | 533 | 1 | 8.14 | 533 | 4338.62 | 2015 | Yes | Yes | Not specified | ||||
| 162 | Republic of Tajikistan | Global Fund | Aurobindo Pharma Ltd. | Lamivudine | 10mg/ml oral solution 240ml | 2.35 | - | 1 | 2.35 | - | - | 2015 | Not specified | Not specified | Not specified | ||||
| 163 | Republic of Moldova | Government | Viiv Healthcare UK Limited | Epivir | Lamivudine | 10mg/ml oral solution 240ml | 31.56 | 344 | 1 | 31.56 | 344 | 10856.64 | Dita Estfarm SRL | 2015 | Not specified | Not specified | Not specified | ||
| 164 | Republic of Moldova | Global Fund | Aurobindo Pharma Ltd. | Lamivudine | 10mg/ml oral solution 240ml | 4.19 | 15 | 1 | 4.19 | 15 | 62.85 | IDA Foundation | Not specified | Not specified | Not specified | ||||
| 165 | Republic of Latvia | Government | Viiv Healthcare UK Limited | Epivir | Lamivudine | 10mg/ml oral solution 240ml | 47.46 | 77 | 1 | 47.46 | 77 | 3654.42 | National Health Service (NHC) | 2016 | Not specified | Not specified | Not specified | ||
| 166 | Republic of Moldova | Government | Viiv Healthcare UK Limited | Epivir | Lamivudine | 10mg/ml oral solution 240ml | 12.89 | 50 | 1 | 12.89 | 50 | 644.5 | Sanfarm-Prim SA | Not specified | Not specified | Not specified | |||
| 167 | Russian Federation | Government | Boehringer Ingelheim | Viramune | Nevirapine (NVP) | 10mg/ml oral solution 240ml | 12.75 | 12170 | 1 | 12.75 | 12170 | 155167.5 | 2015 | Not specified | Not specified | Not specified | |||
| 168 | Russian Federation | Government | Bristol-Myers Squibb | Videx | Didanosine | 125mg caps | 0.84 | 1080 | 30 | 25.2 | 36 | 907.2 | 2016 | Yes | Yes | Not specified | |||
| 169 | Russian Federation | Government | Bristol-Myers Squibb | Videx | Didanosine | 125mg caps | 0.9523 | 37920 | 30 | 28.57 | 1264 | 36112.48 | 2015 | Not specified | Not specified | Not specified | |||
| 170 | Republic of Poland | Government | Bristol-Myers Squibb | Reyataz | Atazanavir (ATV) | 150mg caps | 6.8198 | 6600 | 60 | 409.19 | 110 | 45010.9 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Not specified | ||
| 171 | Russian Federation | Government | Bristol-Myers Squibb | Reyataz | Atazanavir (ATV) | 150mg caps | 1.7975 | 5537820 | 60 | 107.85 | 92297 | 9954231 | 2015 | Not specified | Not specified | Not specified | |||
| 172 | Russian Federation | Government | Bristol-Myers Squibb | Reyataz | Atazanavir (ATV) | 150mg caps | 1.6 | 341100 | 60 | 96 | 5685 | 545760 | 2016 | Yes | Yes | Not specified | |||
| 173 | Republic of Armenia | Global Fund | MYLAN LABORATORIES LTD | Lamivudine | 150mg tab | 0.0333 | 4380 | 60 | 2 | 73 | 146 | partnership for supply. chain management (PFSCM) | 2016 | No | Yes | Not specified | |||
| 174 | Republic of Belarus | Government | Hetero Labs + Фарматех | Lamivudine | 150mg tab | 0.5237 | 836580 | 60 | 31.42 | 13943 | 438089.06 | Фарматех ЗАО | 2015 | Not specified | Not specified | Not specified | |||
| 175 | Russian Federation | Government | ViiV Healthcare | Epivir | Lamivudine | 150mg tab | 0.3435 | 137400 | 60 | 20.61 | 2290 | 47196.9 | 2015 | Not specified | Not specified | Not specified | |||
| 176 | Republic of Poland | Government | Janssen | Prezista | Darunavir (TCM) | 150mg tab | 2.7563 | 1920 | 240 | 661.5 | 8 | 5292 | 2015 | Not specified | Not specified | Not specified | |||
| 177 | Republic of Uzbekistan | Global Fund | Hetero labs Ltd. | Lamivudine | 150mg tab | 0.039 | 60 | 60 | 2.34 | 1 | 2.34 | 2015 | Not specified | Not specified | Not specified | ||||
| 178 | Russian Federation | Government | ViiV Healthcare | Celsentri | Maraviroc | 150mg tab | 3.8402 | 3120 | 60 | 230.41 | 52 | 11981.32 | 2015 | Not specified | Not specified | Not specified | |||
| 179 | Ukraine | Government | Hetero labs Ltd. | Heptavir 150 | Lamivudine | 150mg tab | 0.0348 | 2191020 | 60 | 2.09 | 36517 | 76320.53 | 2016 | Yes | Yes | Not specified | |||
| 180 | Georgia | Global Fund | Aurobindo Pharma Ltd. | Lamivudine | 150mg tab | 0.0358 | 32400 | 60 | 2.15 | 540 | 1161 | partnership for supply. chain management (PFSCM) | 2015 | Not specified | Not specified | Not specified | |||
| 181 | Kyrgyz Republic | Global Fund | Hetero labs Ltd. | Lamivudine | 150mg tab | 0.0383 | - | 60 | 2.3 | - | - | UNDP/UNICEF | 2015 | 2014-12-31 | 2015-12-30 | Not specified | Not specified | Not specified | |
| 182 | Russian Federation | Government | Pharmasyntez | Amiviren | Lamivudine | 150mg tab | 0.03 | 4529280 | 60 | 1.8 | 75488 | 135878.41 | 2016 | Yes | Not specified | Not specified | |||
| 183 | Ukraine | Global Fund | Sun Pharmaceutical Industries Limited | Lamivudine | 150mg tab | 0.0337 | 60 | 60 | 2.02 | 1 | 2.02 | 2015 | Not specified | Not specified | Not specified | ||||
| 184 | Russian Federation | Government | Vial | Lamivudine-Vial | Lamivudine | 150mg tab | 0.3847 | 419220 | 60 | 23.08 | 6987 | 161259.95 | 2015 | Not specified | Not specified | Not specified | |||
| 185 | Republic of Poland | Government | Janssen | Prezista | Darunavir (TCM) | 150mg tab | 2.6382 | 2400 | 240 | 633.16 | 10 | 6331.6 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Yes | Not specified | ||
| 186 | Republic of Moldova | Government | Ranbaxy Laboratories Limited | Avolam | Lamivudine | 150mg tab | 0.05 | 12000 | 60 | 3 | 200 | 600 | Dita Estfarm SRL | 2015 | Yes | Not specified | Not specified | ||
| 187 | Republic of Poland | Government | GlaxoSmithKline | Celsentri | Maraviroc | 150mg tab | 12.8818 | 3600 | 60 | 772.91 | 60 | 46374.6 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Not specified | Not specified | ||
| 188 | Ukraine | Government | Aurobindo Pharma Ltd. | Lamivudine | 150mg tab | 0.0403 | 2190960 | 60 | 2.42 | 36516 | 88368.72 | 2015 | Not specified | Not specified | Not specified | ||||
| 189 | Russian Federation | Government | Aurobindo Pharma Ltd. | Lamivudine | Lamivudine | 150mg tab | 0.16 | 729960 | 60 | 9.6 | 12166 | 116793.6 | 2016 | Yes | Yes | Not specified | |||
| 190 | Russian Federation | Government | Hetero labs Ltd. | Heptavir 150 | Lamivudine | 150mg tab | 0.0647 | 1604940 | 60 | 3.88 | 26749 | 103786.12 | 2015 | Not specified | Not specified | Not specified | |||
| 191 | Russian Federation | Government | Pharmasyntez | Olitid | Abacavir (ABC) | 150mg tab | 0.6933 | 18060 | 60 | 41.6 | 301 | 12521.6 | 2015 | Not specified | Not specified | Not specified | |||
| 192 | Republic of Estonia | Government | ViiV Healthcare | Epivir | Lamivudine | 150mg tab | 3.3902 | 60 | 60 | 203.41 | 1 | 203.41 | 2015 | Not specified | Not specified | Not specified | |||
| 193 | Republic of Armenia | Global Fund | MYLAN LABORATORIES LTD | Lamivudine | 150mg tab | 0.0333 | 2100 | 60 | 2 | 35 | 70 | VPP, through Partnership for Supply Chain Management (PFSCM) | 2015 | 2016-03-11 | 2015-10-14 | Not specified | Not specified | Not specified | |
| 194 | Republic of Tajikistan | Global Fund | Aurobindo Pharma Ltd. | Lamivudine | 150mg tab | 0.035 | 18000 | 60 | 2.1 | 300 | 630 | UNDP/UNICEF | 2016 | Not specified | Not specified | Not specified | |||
| 195 | Republic of Tajikistan | Global Fund | ViiV Healthcare | Lamivudine | 150mg tab | 0.0383 | 60 | 60 | 2.3 | 1 | 2.3 | 2015 | Not specified | Not specified | Not specified | ||||
| 196 | Republic of Kazakhstan | Government | Ranbaxy Laboratories Limited | Lamivudine | 150mg tab | 0.03 | 12740400 | 60 | 1.8 | 212340 | 382212 | 2015 | Not specified | Not specified | Not specified | ||||
| 197 | Republic of Poland | Government | GlaxoSmithKline | Celsentri | Maraviroc | 150mg tab | 12.4953 | 3000 | 60 | 749.72 | 50 | 37486 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Not specified | Not specified | ||
| 198 | Republic of Belarus | Government | Hetero Labs + Фарматех | GEPTAVIR | Lamivudine | 150mg tab | 0.5667 | 836580 | 60 | 34 | 13943 | 474062 | Republican unitary enterprise "BELPHARMATSIYA" | 2015 | 2016-02-04 | 2016-03-31 | Yes | Yes | No |
| 199 | Republic of Poland | Government | ViiV Healthcare | Celsentri | Maraviroc | 150mg tab | 14.1667 | 7200 | 60 | 850 | 120 | 102000 | 2015 | Not specified | Not specified | Not specified | |||
| 200 | Republic of Kazakhstan | Government | ViiV Healthcare | Lamivudine | 150mg tab | 0.0313 | 288000 | 60 | 1.88 | 4800 | 9024 | 2015 | Not specified | Not specified | Not specified | ||||
| 201 | Republic of Poland | Government | Limited t/a Mylan | Lamivudine | Lamivudine | 150mg tab | 0.8813 | 138000 | 60 | 52.88 | 2300 | 121624 | 2015 | Not specified | Not specified | Not specified | |||
| 202 | Republic of Uzbekistan | Global Fund | Hetero labs Ltd. | Lamivudine | Lamivudine | 150mg tab | 0.039 | 60 | 60 | 2.34 | 1 | 2.34 | 2016 | No | Yes | Yes | |||
| 203 | Russian Federation | Government | Pharmasyntez | Amiviren | Lamivudine | 150mg tab | 0.0553 | 22779840 | 60 | 3.32 | 379664 | 1260484.5 | 2015 | Not specified | Not specified | Not specified | |||
| 204 | Republic of Poland | Government | MYLAN LABORATORIES LTD | Lamivudine Mylan | Lamivudine | 150mg tab | 0.7967 | 144000 | 60 | 47.8 | 2400 | 114720 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Not specified | ||
| 205 | Republic of Armenia | Global Fund | MYLAN LABORATORIES LTD | Lamivudine | 150mg tab | 0.0333 | 3720 | 60 | 2 | 62 | 124 | partnership for supply. chain management (PFSCM) | 2016 | No | Yes | Not specified | |||
| 206 | Republiс of Azerbaijan | Government | Aurobindo Pharma Ltd. | Lamivudine | 150mg tab | 0.1945 | 34320 | 60 | 11.67 | 572 | 6675.24 | 2015 | Yes | Yes | Not specified | ||||
| 207 | Republic of Poland | Government | GlaxoSmithKline | Ziagen | Abacavir (ABC) | 150mg tab | 3.4667 | 30000 | 60 | 208 | 500 | 104000 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Not specified | ||
| 208 | Republic of Poland | Government | GlaxoSmithKline | Celsentri | Maraviroc | 150mg tab | 12.8818 | 21600 | 60 | 772.91 | 360 | 278247.59 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Yes | Not specified | ||
| 209 | Russian Federation | Government | Pharmasyntez | Amiviren | Lamivudine | 150mg tab | 0.029 | 4529280 | 60 | 1.74 | 75488 | 131349.12 | 2016 | Yes | Yes | Not specified | |||
| 210 | Russian Federation | Government | Aurobindo Pharma Ltd. | Lamivudine | Lamivudine | 150mg tab | 0.1633 | 7787220 | 60 | 9.8 | 129787 | 1271912.62 | 2015 | Not specified | Not specified | Not specified | |||
| 211 | Republic of Poland | Government | ViiV Healthcare | Celsentri | Maraviroc | 150mg tab | 14.1667 | 2400 | 60 | 850 | 40 | 34000 | 2015 | Not specified | Not specified | Not specified | |||
| 212 | Republic of Poland | Government | Gilead Sciences | Stribild | Elvitegravis+Cobicistat+Emtricitabin+Tenofovir Disoproxil | 150mg+150mg+200mg+245mg tab | 26.5213 | 120000 | 30 | 795.64 | 4000 | 3182560 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Not specified | ||
| 213 | Republic of Poland | Government | Gilead Sciences | Genvoya | Elvitegravis+Cobicistat+Emtricitabin+Tenofovir Disoproxil | 150mg+150mg+200mg+245mg tab | 25.4607 | 228000 | 30 | 763.82 | 7600 | 5805032 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Not specified | Not specified | ||
| 214 | Republic of Poland | Government | Gilead Sciences | Stribild | Elvitegravis+Cobicistat+Emtricitabin+Tenofovir Disoproxil | 150mg+150mg+200mg+245mg tab | 27.319 | 3600 | 30 | 819.57 | 120 | 98348.4 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Not specified | ||
| 215 | Republic of Poland | Government | Bristol-Myers Squibb | Stribild | Elvitegravis+Cobicistat+Emtricitabin+Tenofovir Disoproxil | 150mg+150mg+200mg+245mg tab | 29.1667 | 75000 | 30 | 875 | 2500 | 2187500 | 2015 | Not specified | Not specified | Not specified | |||
| 216 | Republic of Poland | Government | Bristol-Myers Squibb | Stribild | Elvitegravis+Cobicistat+Emtricitabin+Tenofovir Disoproxil | 150mg+150mg+200mg+245mg tab | 29.1667 | 33000 | 30 | 875 | 1100 | 962500 | 2015 | Not specified | Not specified | Not specified | |||
| 217 | Republic of Poland | Government | Gilead Sciences | Stribild | Elvitegravis+Cobicistat+Emtricitabin+Tenofovir Disoproxil | 150mg+150mg+200mg+245mg tab | 26.5213 | 96000 | 30 | 795.64 | 3200 | 2546048 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Not specified | ||
| 218 | Republic of Poland | Government | Gilead Sciences | Stribild | Elvitegravis+Cobicistat+Emtricitabin+Tenofovir Disoproxil | 150mg+150mg+200mg+245mg tab | 25.7257 | 30000 | 30 | 771.77 | 1000 | 771770 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Not specified | Not specified | ||
| 219 | Republic of Poland | Government | Bristol-Myers Squibb | Stribild | Elvitegravis+Cobicistat+Emtricitabin+Tenofovir Disoproxil | 150mg+150mg+200mg+245mg tab | 29.1667 | 51000 | 30 | 875 | 1700 | 1487500 | 2015 | Not specified | Not specified | Not specified | |||
| 220 | Republic of Moldova | Global Fund | Hetero labs Ltd. | Lamivudine+Nevirapine+Zidovudine - FDC | 150mg+200mg+300mg tab | 0.1543 | 19260 | 60 | 9.26 | 321 | 2972.46 | 2015 | Not specified | Yes | Not specified | ||||
| 221 | Republic of Tajikistan | Global Fund | MYLAN LABORATORIES LTD | Lamivudine+Nevirapine+Zidovudine - FDC | 150mg+200mg+300mg tab | 0.135 | 252000 | 60 | 8.1 | 4200 | 34020 | UNDP/UNICEF | 2016 | Not specified | Not specified | Not specified | |||
| 222 | Republic of Tajikistan | Global Fund | Cipla Ltd | Lamivudine+Nevirapine+Zidovudine - FDC | 150mg+200mg+300mg tab | 0.1567 | 60 | 60 | 9.4 | 1 | 9.4 | 2015 | Not specified | Not specified | Not specified | ||||
| 223 | Republic of Moldova | Government | Ranbaxy Laboratories Limited | Avocomb N | Lamivudine+Nevirapine+Zidovudine - FDC | 150mg+200mg+300mg tab | 0.1913 | 148680 | 30 | 5.74 | 4956 | 28447.44 | Dita Estfarm SRL | 2015 | Not specified | Not specified | Not specified | ||
| 224 | Republic of Armenia | Global Fund | Cipla Ltd | Lamivudine+Nevirapine+Zidovudine - FDC | 150mg+200mg+300mg tab | 0.139 | 15840 | 60 | 8.34 | 264 | 2201.76 | VPP, through Partnership for Supply Chain Management (PFSCM) | 2015 | 2015-03-11 | 2015-10-14 | Not specified | Not specified | Not specified | |
| 225 | Republic of Moldova | Global Fund | Ranbaxy Laboratories Limited | Lamivudine+Nevirapine+Zidovudine - FDC | 150mg+200mg+300mg tab | 0.1543 | 19260 | 60 | 9.26 | 321 | 2972.46 | IDA Foundation | Not specified | Not specified | Not specified | ||||
| 226 | Russian Federation | Government | Pharmasyntez | Dizaverox | Lamivudine+Zidovudine | 150mg+300mg tab | 0.3738 | 17154900 | 60 | 22.43 | 285915 | 6413073.5 | 2015 | Not specified | Not specified | Not specified | |||
| 227 | Republiс of Azerbaijan | Government | ViiV Healthcare | Combivir | Lamivudine+Zidovudine | 150mg+300mg tab | 0.4188 | 437400 | 60 | 25.13 | 7290 | 183197.7 | 2015 | Yes | Yes | Not specified | |||
| 228 | Republic of Kazakhstan | Government | ViiV Healthcare | Lamivudine+Zidovudine | 150mg+300mg tab | 0.0512 | 98622000 | 60 | 3.07 | 1643700 | 5046159 | 2015 | Not specified | Not specified | Not specified | ||||
| 229 | Republic of Lithuania | Insurance Fund | Viiv Healthcare UK Limited | Combivir | Lamivudine+Zidovudine | 150mg+300mg tab | 2.7002 | 60 | 60 | 162.01 | 1 | 162.01 | 2016 | Yes | Yes | Not specified | |||
| 230 | Republic of Poland | Government | MYLAN LABORATORIES LTD | Lamiwudyna/Zydowudyna | Lamivudine+Zidovudine | 150mg+300mg tab | 0.2448 | 114000 | 60 | 14.69 | 1900 | 27911 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Not specified | ||
| 231 | Russian Federation | Government | ViiV Healthcare | Combivir | Lamivudine+Zidovudine | 150mg+300mg tab | 0.5945 | 158040 | 60 | 35.67 | 2634 | 93954.78 | 2015 | Not specified | Not specified | Not specified | |||
| 232 | Russian Federation | Government | Pharmasyntez | Dizaverox | Lamivudine+Zidovudine | 150mg+300mg tab | 0.1935 | 3897840 | 60 | 11.61 | 64964 | 754232.06 | 2016 | Yes | Yes | Not specified | |||
| 233 | Republic of Poland | Government | MYLAN LABORATORIES LTD | Lamiwudyna/Zydowudyna | Lamivudine+Zidovudine | 150mg+300mg tab | 0.2453 | 27000 | 60 | 14.72 | 450 | 6624 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Not specified | ||
| 234 | Republic of Lithuania | Government | Лех Ано | Combivir | Lamivudine+Zidovudine | 150mg+300mg tab | 2.5717 | 60 | 60 | 154.3 | 1 | 154.3 | 2015 | Not specified | Not specified | Not specified | |||
| 235 | Republic of Tajikistan | Global Fund | Micro Labs Ltd. | Lamivudine+Zidovudine | 150mg+300mg tab | 0.1075 | 386640 | 60 | 6.45 | 6444 | 41563.8 | UNDP/UNICEF | 2016 | Not specified | Not specified | Not specified | |||
| 236 | Republic of Poland | Government | Cipla Ltd | LAZIVIR | Lamivudine+Zidovudine | 150mg+300mg tab | 0.2705 | 120000 | 60 | 16.23 | 2000 | 32460 | 2015 | Not specified | Not specified | Not specified | |||
| 237 | Russian Federation | Government | Ranbaxy Laboratories Limited | Virocomb | Lamivudine+Zidovudine | 150mg+300mg tab | 0.1937 | 10800000 | 60 | 11.62 | 180000 | 2091600 | 2016 | Yes | Yes | Not specified | |||
| 238 | Republic of Latvia | Government | Teva BV | Lamivudine / Zidovudine Teva | Lamivudine+Zidovudine | 150mg+300mg tab | 1.1085 | 4980 | 60 | 66.51 | 83 | 5520.33 | National Health Service (NHC) | 2016 | Not specified | Not specified | Not specified | ||
| 239 | Republic of Lithuania | Government | Teva BV | Lamivudine+Zidovudine | 150mg+300mg tab | 2.5717 | 60 | 60 | 154.3 | 1 | 154.3 | 2015 | Not specified | Not specified | Not specified | ||||
| 240 | Georgia | Global Fund | Ranbaxy Laboratories Limited | Lamivudine+Zidovudine | 150mg+300mg tab | 0.1058 | 681120 | 60 | 6.35 | 11352 | 72085.2 | partnership for supply. chain management (PFSCM) | 2015 | No | Not specified | Not specified | |||
| 241 | Republic of Moldova | Government | Hetero labs Ltd. | Zidolam | Lamivudine+Zidovudine | 150mg+300mg tab | 0.205 | 132000 | 60 | 12.3 | 2200 | 27060 | Sanfarm-Prim SA | 2015 | Not specified | Not specified | Not specified | ||
| 242 | Russian Federation | Government | Pharmasyntez | Dizaverox | Lamivudine+Zidovudine | 150mg+300mg tab | 0.195 | 1562580 | 60 | 11.7 | 26043 | 304703.09 | 2016 | Yes | Yes | Not specified | |||
| 243 | Republic of Estonia | Government | ViiV Healthcare | Combivir | Lamivudine+Zidovudine | 150mg+300mg tab | 4.9187 | 60 | 60 | 295.12 | 1 | 295.12 | 2015 | Not specified | Not specified | Not specified | |||
| 244 | Republic of Latvia | Government | Teva BV | Lamivudine / Zidovudine Teva | Lamivudine+Zidovudine | 150mg+300mg tab | 0.9232 | 60 | 60 | 55.39 | 1 | 55.39 | 2015 | Not specified | Not specified | Not specified | |||
| 245 | Republic of Belarus | Government | Hetero Labs + Фарматех | Lamivudine+Zidovudine | 150mg+300mg tab | 0.243 | 2568660 | 60 | 14.58 | 42811 | 624184.38 | Фарматех ЗАО | 2015 | Not specified | Not specified | Not specified | |||
| 246 | Republic of Moldova | Government | Aurobindo Pharma Ltd. | Lamivudine+Zidovudine | 150mg+300mg tab | 0.198 | 25200 | 60 | 11.88 | 420 | 4989.6 | Dita Estfarm SRL | Not specified | Not specified | Not specified | ||||
| 247 | Russian Federation | Government | Hetero labs Ltd. | Zidolam | Lamivudine+Zidovudine | 150mg+300mg tab | 0.3568 | 11943840 | 60 | 21.41 | 199064 | 4261960 | 2015 | Not specified | Not specified | Not specified | |||
| 248 | Republic of Kazakhstan | Government | MYLAN LABORATORIES LTD | Lamivudine+Zidovudine | 150mg+300mg tab | 0.033 | 27846000 | 60 | 1.98 | 464100 | 918918 | 2015 | Not specified | Not specified | Not specified | ||||
| 249 | Georgia | Global Fund | Arcolab LTD | Combivir | Lamivudine+Zidovudine | 150mg+300mg tab | 0.0875 | 125340 | 60 | 5.25 | 2089 | 10967.25 | partnership for supply. chain management (PFSCM) | 2016 | Yes | Not specified | Yes | ||
| 250 | Republic of Lithuania | Insurance Fund | Лех Ано | Combivir | Lamivudine+Zidovudine | 150mg+300mg tab | 2.7002 | 60 | 60 | 162.01 | 1 | 162.01 | 2016 | Yes | Yes | Not specified | |||
| 251 | Ukraine | Global Fund | Hetero labs Ltd. | Lamivudine+Zidovudine | 150mg+300mg tab | 0.1042 | 60 | 60 | 6.25 | 1 | 6.25 | 2015 | Not specified | Not specified | Not specified | ||||
| 252 | Republic of Uzbekistan | Global Fund | MYLAN LABORATORIES LTD | Lamivudine+Zidovudine | 150mg+300mg tab | 0.1183 | 60 | 60 | 7.1 | 1 | 7.1 | 2015 | Not specified | Not specified | Not specified | ||||
| 253 | Ukraine | Government | Hetero labs Ltd. | Lamivudine+Zidovudine | 150mg+300mg tab | 0.0945 | 5853900 | 60 | 5.67 | 97565 | 553193.56 | 2016 | Yes | Not specified | Not specified | ||||
| 254 | Republic of Belarus | Government | Hetero Labs + Фарматех | ZIDOLAM | Lamivudine+Zidovudine | 150mg+300mg tab | 0.2667 | 2568660 | 60 | 16 | 42811 | 684976 | Republican unitary enterprise "BELPHARMATSIYA" | 2015 | 2016-02-18 | Yes | Yes | No | |
| 255 | Republic of Uzbekistan | Global Fund | MYLAN LABORATORIES LTD | Lamiwudyna/Zydowudyna | Lamivudine+Zidovudine | 150mg+300mg tab | 0.1183 | 60 | 60 | 7.1 | 1 | 7.1 | 2016 | Yes | Yes | Not specified | |||
| 256 | Russian Federation | Government | Ranbaxy Laboratories Limited | Virocomb | Lamivudine+Zidovudine | 150mg+300mg tab | 0.5285 | 6358380 | 60 | 31.71 | 105973 | 3360403.75 | 2015 | Not specified | Not specified | Not specified | |||
| 257 | Kyrgyz Republic | Global Fund | Hetero labs Ltd. | Lamivudine+Zidovudine | 150mg+300mg tab | 0.1152 | - | 60 | 6.91 | - | - | UNDP/UNICEF | 2015 | 2014-12-31 | 2015-12-30 | Not specified | Not specified | Not specified | |
| 258 | Republic of Lithuania | Insurance Fund | Teva BV | Combivir | Lamivudine+Zidovudine | 150mg+300mg tab | 2.7002 | 60 | 60 | 162.01 | 1 | 162.01 | 2016 | Yes | Yes | Yes | |||
| 259 | Republic of Latvia | Government | ViiV Healthcare | Combivir | Lamivudine+Zidovudine | 150mg+300mg tab | 0.9232 | 60 | 60 | 55.39 | 1 | 55.39 | 2015 | Not specified | Not specified | Not specified | |||
| 260 | Republic of Moldova | Global Fund | Hetero labs Ltd. | Lamivudine+Zidovudine | 150mg+300mg tab | 0.1237 | 37740 | 60 | 7.42 | 629 | 4667.18 | IDA Foundation | 2015 | Not specified | Yes | Not specified | |||
| 261 | Russian Federation | Government | Anhui Biochem United Pharmaceutical Co. | Zidovudine+Lamivudine-Vial | Lamivudine+Zidovudine | 150mg+300mg tab | 0.195 | 450000 | 60 | 11.7 | 7500 | 87750 | 2016 | Yes | Yes | Not specified | |||
| 262 | Republic of Lithuania | Government | Viiv Healthcare UK Limited | Combivir | Lamivudine+Zidovudine | 150mg+300mg tab | 2.5717 | 60 | 60 | 154.3 | 1 | 154.3 | 2015 | Not specified | Not specified | Not specified | |||
| 263 | Ukraine | Government | Aurobindo Pharma Ltd. | Lamivudine+Zidovudine | 150mg+300mg tab | 0.1057 | 5853900 | 60 | 6.34 | 97565 | 618562.12 | 2015 | Not specified | Not specified | Not specified | ||||
| 264 | Republic of Latvia | Government | Viiv Healthcare UK Limited | Combivir | Lamivudine+Zidovudine | 150mg+300mg tab | 1.1085 | 197340 | 60 | 66.51 | 3289 | 218751.39 | National Health Service (NHC) | 2016 | Not specified | Not specified | Not specified | ||
| 265 | Russian Federation | Government | Pharmasyntez | ZILACOMB | Lamivudine+Zidovudine | 150mg+300mg tab | 0.195 | 1260000 | 60 | 11.7 | 21000 | 245700 | 2016 | Yes | Yes | Yes | |||
| 266 | Republic of Moldova | Global Fund | Ranbaxy Laboratories Limited | Lamivudine+Zidovudine | 150mg+300mg tab | 0.1237 | 75480 | 60 | 7.42 | 1258 | 9334.36 | IDA Foundation | Not specified | Not specified | Not specified | ||||
| 267 | Republic of Tajikistan | Global Fund | ViiV Healthcare | Lamivudine+Zidovudine | 150mg+300mg tab | 0.1183 | 60 | 60 | 7.1 | 1 | 7.1 | 2015 | Not specified | Not specified | Not specified | ||||
| 268 | Georgia | Global Fund | Arcolab LTD | Combivir | Lamivudine+Zidovudine | 150mg+300mg tab | 0.105 | 192850 | 50 | 5.25 | 3857 | 20249.25 | partnership for supply. chain management (PFSCM) | 2016 | Yes | Yes | Yes | ||
| 269 | Ukraine | PEPFAR | MYLAN LABORATORIES LTD | Lamiwudyna/Zydowudyna | Lamivudine+Zidovudine | 150mg+300mg tab | 0.0992 | 4686720 | 60 | 5.95 | 78112 | 464766.41 | 2016 | Yes | Not specified | Not specified | |||
| 270 | Russian Federation | Government | Pharmasyntez | Dizaverox | Lamivudine+Zidovudine | 150mg+300mg tab | 0.12 | 167820 | 60 | 7.2 | 2797 | 20138.4 | 2016 | Yes | Yes | Not specified | |||
| 271 | Republic of Moldova | Global Fund | Hetero labs Ltd. | Lamivudine+Zidovudine | 150mg+300mg tab | 0.1237 | 37680 | 60 | 7.42 | 628 | 4659.76 | 2015 | Not specified | Not specified | Not specified | ||||
| 272 | Republic of Armenia | Global Fund | MYLAN LABORATORIES LTD | Lamivudine+Zidovudine | 150mg+300mg tab | 0.11 | 49380 | 60 | 6.6 | 823 | 5431.8 | VPP, through Partnership for Supply Chain Management (PFSCM) | 2015 | 2015-03-11 | 2015-10-14 | Not specified | Not specified | Not specified | |
| 273 | Russian Federation | Government | Bristol-Myers Squibb | Zerit | Stavudine (d4T) | 1mg/ml powder 260ml | 11.9 | 4544 | 1 | 11.9 | 4544 | 54073.6 | 2015 | Not specified | Not specified | Not specified | |||
| 274 | Republic of Poland | Government | Bristol-Myers Squibb | Reyataz | Atazanavir (ATV) | 200mg caps | 7.5 | 13800 | 60 | 450 | 230 | 103500 | 2015 | Not specified | Not specified | Not specified | |||
| 275 | Republic of Poland | Government | Gilead Sciences | Emtriva | Emtricitabine | 200mg caps | 8.3293 | 1800 | 30 | 249.88 | 60 | 14992.8 | 2015 | Not specified | Not specified | Not specified | |||
| 276 | Russian Federation | Government | Bristol-Myers Squibb | Reyataz | Atazanavir (ATV) | 200mg caps | 1.6 | 511500 | 60 | 96 | 8525 | 818400 | 2016 | Yes | Yes | Not specified | |||
| 277 | Republic of Poland | Government | Gilead Sciences | Emtriva | Emtricitabine | 200mg caps | 7.9727 | 750 | 30 | 239.18 | 25 | 5979.5 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Yes | Not specified | ||
| 278 | Republic of Poland | Government | Bristol-Myers Squibb | Reyataz | Atazanavir (ATV) | 200mg caps | 6.6152 | 3000 | 60 | 396.91 | 50 | 19845.5 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Not specified | Not specified | ||
| 279 | Republic of Poland | Government | Gilead Sciences | Emtriva | Emtricitabine | 200mg caps | 9.28 | 1800 | 30 | 278.4 | 60 | 16704 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Not specified | Not specified | ||
| 280 | Russian Federation | Government | Bristol-Myers Squibb | Reyataz | Atazanavir (ATV) | 200mg caps | 2.3747 | 10007940 | 60 | 142.48 | 166799 | 23765522 | 2015 | Not specified | Not specified | Not specified | |||
| 281 | Russian Federation | Government | Bristol-Myers Squibb | Reyataz | Atazanavir (ATV) | 200mg caps | 2.137 | 1038960 | 60 | 128.22 | 17316 | 2220257.5 | 2016 | Yes | Yes | Not specified | |||
| 282 | Republic of Poland | Government | Gilead Sciences | Emtriva | Emtricitabine | 200mg caps | 8.3293 | 2100 | 30 | 249.88 | 70 | 17491.6 | 2015 | Not specified | Not specified | Not specified | |||
| 283 | Russian Federation | Government | Bristol-Myers Squibb | Reyataz | Atazanavir (ATV) | 200mg caps | 2.137 | 692640 | 60 | 128.22 | 11544 | 1480171.62 | 2016 | Yes | Yes | Not specified | |||
| 284 | Russian Federation | Government | AZT PHARMA K.B. | Nikavir | Phosphazide | 200mg tab | 0.641 | 2072380 | 20 | 12.82 | 103619 | 1328395.62 | 2015 | Not specified | Not specified | Not specified | |||
| 285 | Republic of Moldova | Global Fund | Aurobindo Pharma Ltd. | Nevirapine (NVP) | 200mg tab | 0.063 | 10020 | 60 | 3.78 | 167 | 631.26 | 2015 | Not specified | Not specified | Not specified | ||||
| 286 | Republic of Tajikistan | Global Fund | Hetero labs Ltd. | Nevirapine (NVP) | 200mg tab | 0.04 | 63360 | 60 | 2.4 | 1056 | 2534.4 | UNDP/UNICEF | 2016 | Not specified | Not specified | Not specified | |||
| 287 | Republic of Uzbekistan | Global Fund | Strides Arcolab Limited | Efavirenz | Efavirenz | 200mg tab | 0.1033 | 90 | 90 | 9.3 | 1 | 9.3 | 2016 | No | Yes | Yes | |||
| 288 | Russian Federation | Government | Pharmasyntez | Nevirpine | Nevirapine (NVP) | 200mg tab | 0.3198 | 2700720 | 60 | 19.19 | 45012 | 863780.25 | 2015 | Not specified | Not specified | Not specified | |||
| 289 | Republic of Tajikistan | Global Fund | Strides Arcolab Limited | Efavirenz | 200mg tab | 0.1033 | 90 | 90 | 9.3 | 1 | 9.3 | 2015 | Not specified | Not specified | Not specified | ||||
| 290 | Russian Federation | Government | Pharmasyntez | Emtritab | Emtricitabine | 200mg tab | 0.19 | 14160 | 30 | 5.7 | 472 | 2690.4 | 2016 | Yes | Yes | Yes | |||
| 291 | Republic of Latvia | Government | Boehringer Ingelheim | Viramune | Nevirapine (NVP) | 200mg tab | 3.0802 | 60 | 60 | 184.81 | 1 | 184.81 | 2015 | Not specified | Not specified | Not specified | |||
| 292 | Republic of Uzbekistan | Global Fund | Strides Arcolab Limited | Efavirenz | 200mg tab | 0.1033 | 90 | 90 | 9.3 | 1 | 9.3 | 2015 | Not specified | Not specified | Not specified | ||||
| 293 | Georgia | Global Fund | Strides Arcolab Limited | Efavirenz | 200mg tab | 0.1033 | 32400 | 90 | 9.3 | 360 | 3348 | partnership for supply. chain management (PFSCM) | 2015 | Not specified | Yes | Not specified | |||
| 294 | Republic of Moldova | Government | Ranbaxy Laboratories Limited | Nevipan | Nevirapine (NVP) | 200mg tab | 0.0543 | 30000 | 60 | 3.26 | 500 | 1630 | Dita Estfarm SRL | 2015 | Not specified | Not specified | Not specified | ||
| 295 | Russian Federation | Government | Johnson & Johnson | Intelence | Etravirine | 200mg tab | 5.4245 | 2799660 | 60 | 325.47 | 46661 | 15186756 | 2015 | Not specified | Not specified | Not specified | |||
| 296 | Republic of Armenia | Global Fund | Strides Shasun | Efavirenz | 200mg tab | 0.1033 | 3060 | 90 | 9.3 | 34 | 316.2 | partnership for supply. chain management (PFSCM) | 2016 | No | Yes | Not specified | |||
| 297 | Kyrgyz Republic | Global Fund | Strides Arcolab Limited | Efavirenz | 200mg tab | 0.1033 | 89370 | 90 | 9.3 | 993 | 9234.9 | UNDP/UNICEF | 2015 | 2014-12-31 | 2015-12-30 | Not specified | Not specified | Not specified | |
| 298 | Republic of Poland | Government | Boehringer Ingelheim | Viramune | Nevirapine (NVP) | 200mg tab | 0.7968 | 156000 | 60 | 47.81 | 2600 | 124306 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Not specified | ||
| 299 | Republic of Tajikistan | Global Fund | Aurobindo Pharma Ltd. | Nevirapine (NVP) | 200mg tab | 0.0408 | 60 | 60 | 2.45 | 1 | 2.45 | 2015 | Not specified | Not specified | Not specified | ||||
| 300 | Ukraine | PEPFAR | Hetero labs Ltd. | Невивир | Nevirapine (NVP) | 200mg tab | 0.03 | 396000 | 60 | 1.8 | 6600 | 11880 | 2016 | Yes | Yes | Yes | |||
| 301 | Republic of Moldova | Global Fund | Aurobindo Pharma Ltd. | Efavirenz | 200mg tab | 0.1436 | 13680 | 90 | 12.92 | 152 | 1963.84 | IDA Foundation | 2016 | Not specified | Not specified | Not specified | |||
| 302 | Republic of Armenia | Global Fund | MYLAN LABORATORIES LTD | Nevirapine (NVP) | 200mg tab | 0.0367 | 15540 | 60 | 2.2 | 259 | 569.8 | partnership for supply. chain management (PFSCM) | 2016 | No | Yes | Not specified | |||
| 303 | Republiс of Azerbaijan | Government | Hetero labs Ltd. | Nevirapine (NVP) | 200mg tab | 0.1915 | 114060 | 60 | 11.49 | 1901 | 21842.49 | 2015 | Yes | Yes | Not specified | ||||
| 304 | Republic of Armenia | Global Fund | MYLAN LABORATORIES LTD | Nevirapine (NVP) | 200mg tab | 0.0367 | 11460 | 60 | 2.2 | 191 | 420.2 | VPP, through Partnership for Supply Chain Management (PFSCM) | 2015 | 2015-03-11 | 2015-10-14 | Not specified | Not specified | Not specified | |
| 305 | Georgia | Global Fund | Arcolab LTD | Sustiva | Efavirenz | 200mg tab | 0.31 | 4230 | 30 | 9.3 | 141 | 1311.3 | partnership for supply. chain management (PFSCM) | 2016 | Yes | Yes | Yes | ||
| 306 | Republic of Poland | Government | Janssen | Intelence | Etravirine | 200mg tab | 5.902 | 21000 | 60 | 354.12 | 350 | 123942 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Not specified | Yes | ||
| 307 | Russian Federation | Government | ARS Pharm | Efavirenz | Efavirenz | 200mg tab | 0.2497 | 2850 | 30 | 7.49 | 95 | 711.55 | 2015 | Not specified | Not specified | Not specified | |||
| 308 | Ukraine | Government | Strides Arcolab Limited | Efavirenz | Efavirenz | 200mg tab | 0.1148 | 92520 | 90 | 10.33 | 1028 | 10619.24 | 2016 | Yes | Yes | Yes | |||
| 309 | Republic of Poland | Government | Johnson & Johnson | Intelence | Etravirine | 200mg tab | 6.6915 | 40500 | 60 | 401.49 | 675 | 271005.75 | 2015 | Not specified | Not specified | Not specified | |||
| 310 | Republic of Belarus | Government | Hetero Labs + Фарматех | Nevivir | Nevirapine (NVP) | 200mg tab | 0.05 | 640320 | 60 | 3 | 10672 | 32016 | Republican unitary enterprise "BELPHARMATSIYA" | 2015 | 2016-02-18 | Yes | Yes | No | |
| 311 | Republic of Poland | Government | Merck Sharp & Dohme | Stocrin | Efavirenz | 200mg tab | 2.9522 | 10800 | 90 | 265.7 | 120 | 31884 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Yes | Not specified | ||
| 312 | Kyrgyz Republic | Global Fund | Strides Arcolab Limited | Nevirapine (NVP) | 200mg tab | 0.0375 | - | 60 | 2.25 | - | - | UNDP/UNICEF | 2015 | 2014-12-31 | 2015-12-30 | Not specified | Not specified | Not specified | |
| 313 | Russian Federation | Government | Merck Sharp & Dohme | Stocrin | Efavirenz | 200mg tab | 0.2229 | 172620 | 90 | 20.06 | 1918 | 38475.08 | 2015 | Not specified | Not specified | Not specified | |||
| 314 | Russian Federation | Government | Drugs technology | Nevirapine-TL | Nevirapine (NVP) | 200mg tab | 0.1242 | 1016820 | 60 | 7.45 | 16947 | 126255.15 | 2015 | Not specified | Not specified | Not specified | |||
| 315 | Republic of Poland | Government | Johnson & Johnson | Intelence | Etravirine | 200mg tab | 6.6915 | 18000 | 60 | 401.49 | 300 | 120447 | 2015 | Not specified | Not specified | Not specified | |||
| 316 | Republic of Moldova | Government | Ranbaxy Laboratories Limited | Aviranz | Efavirenz | 200mg tab | 0.08 | 11250 | 90 | 7.2 | 125 | 900 | Dita Estfarm SRL | 2015 | Not specified | Not specified | Yes | ||
| 317 | Ukraine | Global Fund | Hetero labs Ltd. | Nevirapine (NVP) | 200mg tab | 0.0412 | 60 | 60 | 2.47 | 1 | 2.47 | 2015 | Not specified | Not specified | Not specified | ||||
| 318 | Republic of Poland | Government | MYLAN LABORATORIES LTD | Nevirapine Mylan | Nevirapine (NVP) | 200mg tab | 0.8102 | 7800 | 60 | 48.61 | 130 | 6319.3 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Not specified | ||
| 319 | Republic of Moldova | Global Fund | Hetero labs Ltd. | Nevirapine (NVP) | 200mg tab | 0.063 | 20040 | 60 | 3.78 | 334 | 1262.52 | IDA Foundation | Not specified | Not specified | Not specified | ||||
| 320 | Ukraine | Government | Strides Arcolab Limited | Efavirenz | 200mg tab | 0.1172 | 92430 | 90 | 10.55 | 1027 | 10834.85 | 2015 | Not specified | Not specified | Not specified | ||||
| 321 | Republic of Kazakhstan | Government | Boehringer Ingelheim | Nevirapine (NVP) | 200mg tab | 0.0103 | 1479600 | 60 | 0.62 | 24660 | 15289.2 | 2015 | Not specified | Not specified | Not specified | ||||
| 322 | Ukraine | Government | Strides Arcolab Limited | Nevirapine (NVP) | 200mg tab | 0.0417 | 423360 | 60 | 2.5 | 7056 | 17640 | 2015 | Not specified | Not specified | Not specified | ||||
| 323 | Russian Federation | Government | AZT PHARMA K.B. | Nikavir | Phosphazide | 200mg tab | 0.53 | 2941240 | 20 | 10.6 | 147062 | 1558857.25 | 2016 | Yes | Yes | Not specified | |||
| 324 | Kyrgyz Republic | Global Fund | Strides Arcolab Limited | Efavirenz | 200mg tab | 0.1033 | 89370 | 90 | 9.3 | 993 | 9234.9 | UNDP/UNICEF | 2016 | No | No | Not specified | |||
| 325 | Republic of Moldova | Government | Ranbaxy Laboratories Limited | Nevirapine (NVP) | 200mg tab | 0.0817 | 19140 | 60 | 4.9 | 319 | 1563.1 | Sanfarm-Prim SA | Not specified | Not specified | Not specified | ||||
| 326 | Russian Federation | Government | Janssen | Intelence | Etravirine | 200mg tab | 4.5567 | 1136400 | 60 | 273.4 | 18940 | 5178196 | 2016 | Yes | Yes | Yes | |||
| 327 | Republic of Uzbekistan | Global Fund | Aurobindo Pharma Ltd. | Nevirapine | Nevirapine (NVP) | 200mg tab | 0.04 | 60 | 60 | 2.4 | 1 | 2.4 | 2016 | Yes | Yes | Yes | |||
| 328 | Republic of Poland | Government | Boehringer Ingelheim | Viramune | Nevirapine (NVP) | 200mg tab | 0.7968 | 156000 | 60 | 47.81 | 2600 | 124306 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Not specified | ||
| 329 | Republic of Armenia | Global Fund | Strides Arcolab Limited | Efavirenz | 200mg tab | 0.1033 | 2340 | 90 | 9.3 | 26 | 241.8 | VPP, through Partnership for Supply Chain Management (PFSCM) | 2015 | 2015-03-11 | Not specified | Not specified | Not specified | ||
| 330 | Republic of Kazakhstan | Government | Emcure Pharmaceuticals Ltd. | Nevirapine (NVP) | 200mg tab | 0.0103 | 45568800 | 60 | 0.62 | 759480 | 470877.59 | 2015 | Not specified | Not specified | Not specified | ||||
| 331 | Ukraine | Global Fund | Hetero labs Ltd. | Невивир | Nevirapine (NVP) | 200mg tab | 0.0412 | 856980 | 60 | 2.47 | 14283 | 35279.01 | 2016 | Yes | Yes | Yes | |||
| 332 | Republic of Moldova | Global Fund | Strides Arcolab Limited | Efavirenz | 200mg tab | 0.1436 | 13680 | 90 | 12.92 | 152 | 1963.84 | IDA Foundation | 2015 | Not specified | Yes | Not specified | |||
| 333 | Republic of Uzbekistan | Global Fund | Aurobindo Pharma Ltd. | Nevirapine (NVP) | 200mg tab | 0.04 | 60 | 60 | 2.4 | 1 | 2.4 | 2015 | Not specified | Not specified | Not specified | ||||
| 334 | Republic of Armenia | Global Fund | Strides Shasun | Nevirapine (NVP) | 200mg tab | 0.0367 | 30120 | 60 | 2.2 | 502 | 1104.4 | partnership for supply. chain management (PFSCM) | 2016 | No | Yes | Not specified | |||
| 335 | Republic of Moldova | Global Fund | Aurobindo Pharma Ltd. | Nevirapine (NVP) | 200mg tab | 0.063 | 10020 | 60 | 3.78 | 167 | 631.26 | IDA Foundation | 2015 | Not specified | Yes | Not specified | |||
| 336 | Republic of Kazakhstan | Government | Zhangjiagang Huachang Pharmaceutical Industry Limited Company, China | Efavirenz | 200mg tab | 0.016 | 2624400 | 90 | 1.44 | 29160 | 41990.4 | 2015 | Not specified | Not specified | Not specified | ||||
| 337 | Republic of Poland | Government | Merck Sharp & Dohme | Stocrin | Efavirenz | 200mg tab | 2.9522 | 4500 | 90 | 265.7 | 50 | 13285 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Not specified | ||
| 338 | Russian Federation | Government | Pharmasyntez | Nevirpine | Nevirapine (NVP) | 200mg tab | 0.1 | 499620 | 60 | 6 | 8327 | 49962 | 2016 | Yes | Yes | Not specified | |||
| 339 | Georgia | Global Fund | Arcolab LTD | Nevirapine (NVP) | 200mg tab | 0.0367 | 170100 | 60 | 2.2 | 2835 | 6237 | partnership for supply. chain management (PFSCM) | 2016 | Yes | Yes | Not specified | |||
| 340 | Republic of Poland | Government | Merck Sharp & Dohme | Stocrin | Efavirenz | 200mg tab | 3.2467 | 4500 | 90 | 292.2 | 50 | 14610 | 2015 | Not specified | Not specified | Not specified | |||
| 341 | Republiс of Azerbaijan | Government | Strides Arcolab Limited | Efavirenz | 200mg tab | 0.2588 | 19080 | 90 | 23.29 | 212 | 4937.48 | 2015 | Yes | Yes | Not specified | ||||
| 342 | Republic of Tajikistan | Global Fund | Strides Arcolab Limited | Efavirenz | 200mg tab | 0.1033 | 87480 | 90 | 9.3 | 972 | 9039.6 | UNDP/UNICEF | Not specified | Not specified | Not specified | ||||
| 343 | Republic of Poland | Government | Gilead Sciences | Truvada | Emtricitabine+Tenofovir - FDC | 200mg+245mg tab | 17.2693 | 181500 | 30 | 518.08 | 6050 | 3134384 | 2015 | Not specified | Not specified | Not specified | |||
| 344 | Republic of Latvia | Government | Gilead Sciences | Truvada | Emtricitabine+Tenofovir - FDC | 200mg+245mg tab | 15.6427 | 30 | 30 | 469.28 | 1 | 469.28 | 2015 | Not specified | Not specified | Not specified | |||
| 345 | Republic of Latvia | Government | Gilead Sciences | Truvada | Emtricitabine+Tenofovir - FDC | 200mg+245mg tab | 17.6727 | 69420 | 30 | 530.18 | 2314 | 1226836.5 | National Health Service (NHC) | 2016 | Not specified | Not specified | Not specified | ||
| 346 | Republic of Poland | Government | Gilead Sciences | Eviplera | Emtricitabine+Rilpivirine+Tenofovir | 200mg+25mg+245mg tab | 23.6147 | 102000 | 30 | 708.44 | 3400 | 2408696 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Not specified | Not specified | ||
| 347 | Republic of Poland | Government | Gilead Sciences | Eviplera | Emtricitabine+Rilpivirine+Tenofovir | 200mg+25mg+245mg tab | 26.7733 | 201000 | 30 | 803.2 | 6700 | 5381440 | 2015 | Not specified | Not specified | Not specified | |||
| 348 | Republic of Poland | Government | Gilead Sciences | Eviplera | Emtricitabine+Rilpivirine+Tenofovir | 200mg+25mg+245mg tab | 26.7733 | 30000 | 30 | 803.2 | 1000 | 803200 | 2015 | Not specified | Not specified | Not specified | |||
| 349 | Republic of Poland | Government | Gilead Sciences | Odefsey | Emtricitabine+Rilpivirine+Tenofovir | 200mg+25mg+245mg tab | 23.3863 | 159000 | 30 | 701.59 | 5300 | 3718427 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Not specified | Not specified | ||
| 350 | Republic of Poland | Government | Gilead Sciences | Eviplera | Emtricitabine+Rilpivirine+Tenofovir | 200mg+25mg+245mg tab | 26.7733 | 73500 | 30 | 803.2 | 2450 | 1967840 | 2015 | Not specified | Not specified | Not specified | |||
| 351 | Republic of Kazakhstan | Government | Gilead Sciences | Emtricitabine+Tenofovir - FDC | 200mg+300mg tab | 0.1187 | 7237800 | 30 | 3.56 | 241260 | 858885.62 | 2015 | Not specified | Not specified | Not specified | ||||
| 352 | Kyrgyz Republic | Global Fund | MYLAN LABORATORIES LTD | Emtricitabine+Tenofovir - FDC | 200mg+300mg tab | 0.2003 | - | 30 | 6.01 | - | - | UNDP/UNICEF | 2015 | 2014-12-31 | 2015-12-30 | Not specified | Not specified | Not specified | |
| 353 | Republic of Poland | Government | Gilead Sciences | Truvada | Emtricitabine+Tenofovir - FDC | 200mg+300mg tab | 15.7033 | 450000 | 30 | 471.1 | 15000 | 7066500 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Yes | Not specified | ||
| 354 | Republic of Moldova | Global Fund | MYLAN LABORATORIES LTD | Emtricitabine+Tenofovir - FDC | 200mg+300mg tab | 0.2233 | 33120 | 30 | 6.7 | 1104 | 7396.8 | 2015 | Not specified | Not specified | Not specified | ||||
| 355 | Republic of Armenia | Global Fund | MYLAN LABORATORIES LTD | Emtricitabine+Tenofovir - FDC | 200mg+300mg tab | 0.179 | 20220 | 30 | 5.37 | 674 | 3619.38 | VPP, through Partnership for Supply Chain Management (PFSCM) | 2015 | 2016-03-11 | 2015-10-14 | Not specified | Not specified | Not specified | |
| 356 | Georgia | Global Fund | Hetero labs Ltd. | Emtricitabine+Tenofovir - FDC | 200mg+300mg tab | 0.1973 | 824040 | 30 | 5.92 | 27468 | 162610.56 | partnership for supply. chain management (PFSCM) | 2015 | Not specified | Not specified | Not specified | |||
| 357 | Republic of Poland | Government | Gilead Sciences | Truvada | Emtricitabine/Tenofovir Disoproxil Fumarate | 200mg+300mg tab | 15.703 | 180000 | 30 | 471.09 | 6000 | 2826540 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Not specified | ||
| 358 | Ukraine | Global Fund | Macleods Pharmaceuticals Ltd | Тенохоп | Emtricitabine+Tenofovir - FDC | 200mg+300mg tab | 0.1787 | 774990 | 30 | 5.36 | 25833 | 138464.88 | 2016 | Yes | Yes | Yes | |||
| 359 | Republic of Moldova | Global Fund | MYLAN LABORATORIES LTD | Emtricitabine+Tenofovir - FDC | 200mg+300mg tab | 0.2233 | 33120 | 30 | 6.7 | 1104 | 7396.8 | IDA Foundation | 2015 | Not specified | Yes | Not specified | |||
| 360 | Russian Federation | Government | Gilead Sciences | Truvada | Emtricitabine+Tenofovir - FDC | 200mg+300mg tab | 6.9733 | 98970 | 30 | 209.2 | 3299 | 690150.81 | 2015 | Not specified | Not specified | Not specified | |||
| 361 | Republic of Moldova | Global Fund | Hetero labs Ltd. | Emtricitabine+Tenofovir - FDC | 200mg+300mg tab | 0.2233 | 66240 | 30 | 6.7 | 2208 | 14793.6 | IDA Foundation | 2016 | Not specified | Not specified | Not specified | |||
| 362 | Georgia | NCDC Georgia | MYLAN LABORATORIES LTD | Truvada | Emtricitabine+Tenofovir - FDC | 200mg+300mg tab | 0.175 | 246660 | 30 | 5.25 | 8222 | 43165.5 | partnership for supply. chain management (PFSCM) | 2016 | Yes | Yes | Yes | ||
| 363 | Republic of Tajikistan | Global Fund | MYLAN LABORATORIES LTD | Emtricitabine+Tenofovir - FDC | 200mg+300mg tab | 0.179 | 52560 | 30 | 5.37 | 1752 | 9408.24 | UNDP/UNICEF | 2016 | Not specified | Not specified | Not specified | |||
| 364 | Republic of Armenia | Global Fund | MYLAN LABORATORIES LTD | Emtricitabine+Tenofovir - FDC | 200mg+300mg tab | 0.175 | 79320 | 30 | 5.25 | 2644 | 13881 | partnership for supply. chain management (PFSCM) | 2016 | No | Yes | Not specified | |||
| 365 | Republic of Tajikistan | Global Fund | Hetero labs Ltd. | Emtricitabine+Tenofovir - FDC | 200mg+300mg tab | 0.2003 | 30 | 30 | 6.01 | 1 | 6.01 | 2015 | Not specified | Not specified | Not specified | ||||
| 366 | Republic of Armenia | Global Fund | MYLAN LABORATORIES LTD | Emtricitabine+Tenofovir - FDC | 200mg+300mg tab | 0.175 | 86400 | 30 | 5.25 | 2880 | 15120 | partnership for supply. chain management (PFSCM) | 2016 | No | No | Not specified | |||
| 367 | Republic of Belarus | Government | Hetero Labs + Фарматех | Emtricitabine+Tenofovir - FDC | 200mg+300mg tab | 2.3493 | 317610 | 30 | 70.48 | 10587 | 746171.75 | Фарматех ЗАО | 2015 | Not specified | Not specified | Not specified | |||
| 368 | Georgia | NCDC Georgia | Arcolab LTD | Truvada | Emtricitabine/Tenofovir Disoproxil Fumarate | 200mg+300mg tab | 0.1667 | 803010 | 30 | 5 | 26767 | 133835 | partnership for supply. chain management (PFSCM) | 2016 | Yes | Yes | Yes | ||
| 369 | Republic of Belarus | Government | Hetero Labs + Фарматех | Emtricitabine+Tenofovir - FDC | 200mg+300mg tab | 1.2833 | 635220 | 60 | 77 | 10587 | 815199 | 2016 | Not specified | Yes | Not specified | ||||
| 370 | Ukraine | Global Fund | Macleods Pharmaceuticals Ltd | Emtricitabine+Tenofovir - FDC | 200mg+300mg tab | 0.1787 | 30 | 30 | 5.36 | 1 | 5.36 | 2015 | Not specified | Not specified | Not specified | ||||
| 371 | Republic of Poland | Government | Gilead Sciences | Atripla | Emtricitabine+Rilpivirine+Tenofovir | 200mg+300mg+25mg tab | 24.0383 | 51000 | 30 | 721.15 | 1700 | 1225955 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Not specified | ||
| 372 | Russian Federation | Government | Gilead Sciences | Eviplera | Rilpivirine + Tenofovir + Emtricitabine | 200mg+300mg+25mg tab | 13.125 | 47460 | 30 | 393.75 | 1582 | 622912.5 | 2016 | Yes | Yes | Not specified | |||
| 373 | Republic of Poland | Government | Gilead Sciences | Eviplera | Emtricitabine+Rilpivirine+Tenofovir | 200mg+300mg+25mg tab | 24.345 | 135000 | 30 | 730.35 | 4500 | 3286575 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Yes | Not specified | ||
| 374 | Republic of Poland | Government | Gilead Sciences | Eviplera | Emtricitabine+Rilpivirine+Tenofovir | 200mg+300mg+25mg tab | 24.345 | 75000 | 30 | 730.35 | 2500 | 1825875 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Not specified | ||
| 375 | Russian Federation | Government | Gilead Sciences | Eviplera | Emtricitabine+Rilpivirine+Tenofovir | 200mg+300mg+25mg tab | 29.5103 | 20940 | 30 | 885.31 | 698 | 617946.38 | 2015 | Not specified | Not specified | Not specified | |||
| 376 | Republic of Tajikistan | Global Fund | Aurobindo Pharma Ltd. | Lopinavir+Ritonavir - FDC | 200mg+50mg tab | 0.5067 | 120 | 120 | 60.8 | 1 | 60.8 | 2015 | Not specified | Not specified | Not specified | ||||
| 377 | Republic of Poland | Government | Gilead Sciences | Descovy Emtricitabine/Tenofovir alafenamide 10/200 mg | Tenofovir/Emtricitabinum | 200mg+50mg tab | 14.1327 | 301860 | 30 | 423.98 | 10062 | 4266087 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Not specified | Not specified | ||
| 378 | Republic of Poland | Government | AbbVie | Kaletra | Lopinavir+Ritonavir - FDC | 200mg+50mg tab | 3.4291 | 240000 | 120 | 411.49 | 2000 | 822980 | 2015 | Not specified | Not specified | Not specified | |||
| 379 | Republic of Belarus | Global Fund | AbbVie | Lopinavir+Ritonavir - FDC | 200mg+50mg tab | 0.5067 | 180000 | 120 | 60.8 | 1500 | 91200 | UNICEF Supply Division | 2015 | 2015-11-19 | 2016-02-17 | Not specified | Not specified | Not specified | |
| 380 | Republic of Poland | Government | AbbVie | Kaletra | Lopinavir+Ritonavir - FDC | 200mg+50mg tab | 3.4292 | 1260000 | 120 | 411.5 | 10500 | 4320750 | 2015 | Not specified | Not specified | Not specified | |||
| 381 | Republic of Armenia | Global Fund | AbbVie | Aluvia | Lopinavir+Ritonavir - FDC | 200mg+50mg tab | 0.5067 | 144720 | 120 | 60.8 | 1206 | 73324.8 | partnership for supply. chain management (PFSCM) | 2016 | Yes | Yes | Not specified | ||
| 382 | Republic of Armenia | Global Fund | AbbVie | Lopinavir+Ritonavir - FDC | 200mg+50mg tab | 0.5067 | 84600 | 120 | 60.8 | 705 | 42864 | VPP, through Partnership for Supply Chain Management (PFSCM) | 2015 | 2015-05-11 | 2015-10-14 | Not specified | Not specified | Not specified | |
| 383 | Republic of Latvia | Government | AbbVie | Kaletra | Lopinavir+Ritonavir - FDC | 200mg+50mg tab | 2.9628 | 120 | 120 | 355.54 | 1 | 355.54 | 2015 | Not specified | Not specified | Not specified | |||
| 384 | Ukraine | Global Fund | AbbVie | Lopinavir+Ritonavir - FDC | 200mg+50mg tab | 0.5067 | 120 | 120 | 60.8 | 1 | 60.8 | 2015 | Not specified | Not specified | Not specified | ||||
| 385 | Republic of Moldova | Global Fund | AbbVie | Lopinavir+Ritonavir - FDC | 200mg+50mg tab | 0.5067 | 170160 | 120 | 60.8 | 1418 | 86214.4 | IDA Foundation | 2015 | Not specified | Yes | Not specified | |||
| 386 | Republic of Moldova | Global Fund | AbbVie | Lopinavir+Ritonavir - FDC | 200mg+50mg tab | 0.5067 | 170040 | 120 | 60.8 | 1417 | 86153.6 | 2015 | Not specified | Not specified | Not specified | ||||
| 387 | Republic of Moldova | Global Fund | AbbVie | Aluvia | Lopinavir+Ritonavir - FDC | 200mg+50mg tab | 0.5067 | 340200 | 120 | 60.8 | 2835 | 172368 | IDA Foundation | Not specified | Not specified | Not specified | |||
| 388 | Republic of Estonia | Government | AbbVie | Kaletra | Lopinavir+Ritonavir - FDC | 200mg+50mg tab | 3.6984 | 120 | 120 | 443.81 | 1 | 443.81 | 2015 | Not specified | Not specified | Not specified | |||
| 389 | Republic of Latvia | Government | AbbVie | Kaletra | Lopinavir+Ritonavir - FDC | 200mg+50mg tab | 3.3617 | 237600 | 120 | 403.4 | 1980 | 798732 | National Health Service (NHC) | 2016 | Not specified | Not specified | Not specified | ||
| 390 | Ukraine | PEPFAR | AbbVie | Aluvia | Lopinavir+Ritonavir - FDC | 200mg+50mg tab | 0.5067 | 4215480 | 120 | 60.8 | 35129 | 2135843.25 | 2016 | Yes | Yes | Not specified | |||
| 391 | Republic of Poland | Government | AbbVie | Kaletra | Lopinavir+Ritonavir - FDC | 200mg+50mg tab | 3.6655 | 10200 | 60 | 219.93 | 170 | 37388.1 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Not specified | Not specified | ||
| 392 | Republic of Moldova | Government | AbbVie | Aluvia | Lopinavir+Ritonavir - FDC | 200mg+50mg tab | 0.5771 | 342000 | 120 | 69.25 | 2850 | 197362.5 | Dita Estfarm SRL | 2015 | Not specified | Not specified | Not specified | ||
| 393 | Republic of Uzbekistan | Global Fund | Aurobindo Pharma Ltd. | Lopinavir+Ritonavir | Lopinavir+Ritonavir - FDC | 200mg+50mg tab | 0.0281 | 120 | 120 | 3.37 | 1 | 3.37 | 2016 | Yes | Yes | Yes | |||
| 394 | Republic of Lithuania | Insurance Fund | AbbVie | Kaletra | Lopinavir+Ritonavir - FDC | 200mg+50mg tab | 1.7817 | 60 | 60 | 106.9 | 1 | 106.9 | 2016 | Yes | Yes | Not specified | |||
| 395 | Ukraine | Government | AbbVie | Lopinavir+Ritonavir - FDC | 200mg+50mg tab | 0.5418 | 13032120 | 120 | 65.02 | 108601 | 7061237 | 2016 | Not specified | Not specified | Not specified | ||||
| 396 | Ukraine | Global Fund | AbbVie | Aluvia | Lopinavir+Ritonavir - FDC | 200mg+50mg tab | 0.5067 | 7003080 | 120 | 60.8 | 58359 | 3548227.25 | 2016 | Yes | Yes | Not specified | |||
| 397 | Republic of Uzbekistan | Global Fund | Aurobindo Pharma Ltd. | Lopinavir+Ritonavir - FDC | 200mg+50mg tab | 0.0281 | 120 | 120 | 3.37 | 1 | 3.37 | 2015 | Not specified | Not specified | Not specified | ||||
| 398 | Republic of Belarus | Global Fund | AbbVie | Lopinavir+Ritonavir - FDC | 200mg+50mg tab | 0.5067 | 49800 | 120 | 60.8 | 415 | 25232 | UNICEF Supply Division | 2015 | 2015-12-22 | 2016-03-01 | Not specified | Not specified | Not specified | |
| 399 | Republic of Poland | Government | Gilead Sciences | Descovy Emtricitabine/Tenofovir alafenamide 10/200 mg | Tenofovir/Emtricitabinum | 200mg+50mg tab | 14.1327 | 159000 | 30 | 423.98 | 5300 | 2247094 | Krajowe Centrum ds. AIDS | 2016 | Not specified | Not specified | Not specified | ||
| 400 | Republic of Lithuania | Government | AbbVie | Kaletra | Lopinavir+Ritonavir - FDC | 200mg+50mg tab | 3.3937 | 120 | 120 | 407.25 | 1 | 407.25 | 2015 | Not specified | Yes | Not specified | |||
| 401 | Republic of Belarus | Global Fund | AbbVie | Lopinavir+Ritonavir - FDC | 200mg+50mg tab | 0.5067 | 120000 | 120 | 60.8 | 1000 | 60800 | UNICEF Supply Division | 2015 | 2015-11-04 | 2016-01-30 | Not specified | Not specified | Not specified | |
| 402 | Russian Federation | Government | AbbVie | Kaletra | Lopinavir+Ritonavir - FDC | 200mg+50mg tab | 0.91 | 10272360 | 120 | 109.2 | 85603 | 9347848 | 2016 | Yes | Yes | Not specified | |||
| 403 | Republic of Tajikistan | Global Fund | Aurobindo Pharma Ltd. | Lopinavir+Ritonavir - FDC | 200mg+50mg tab | 0.1667 | 472320 | 120 | 20 | 3936 | 78720 | UNDP/UNICEF | Not specified | Not specified | Not specified | ||||
| 404 | Republic of Belarus | Global Fund | AbbVie | Aluvia | Lopinavir+Ritonavir - FDC | 200mg+50mg tab | 0.5007 | 2096520 | 120 | 60.08 | 17471 | 1049657.62 | UNDP/UNICEF | 2016 | Yes | Yes | Not specified | ||
| 405 | Republic of Belarus | Global Fund | AbbVie | Lopinavir+Ritonavir - FDC | 200mg+50mg tab | 0.5067 | 848160 | 120 | 60.8 | 7068 | 429734.41 | UNICEF Supply Division | 2015 | 2015-11-25 | 2016-03-01 | Not specified | Not specified | Not specified | |
| 406 | Republic of Armenia | Global Fund | AbbVie | Aluvia | Lopinavir+Ritonavir - FDC | 200mg+50mg tab | 0.5067 | 111600 | 120 | 60.8 | 930 | 56544 | partnership for supply. chain management (PFSCM) | 2016 | Yes | Yes | Not specified | ||
| 407 | Republiс of Azerbaijan | Government | AbbVie |